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The epidermal growth factor (EGF)-like domain is an evolutionarily conserved 
modular protein subunit. Despite hypervariability of amino acid sequences in 
their inter-cysteine region, they preferentially fold into a three-looped 
conformation with a disulfide pairing of C1-C3 , C2-C4, C5-C6.  To elucidate the 
structural determinants that dictates the canonical EGF-like domain fold, we 
had chosen the fourth and fifth EGF-like domain of thrombomodulin (TM) as 
models.  While the fourth EGF-like domain folds into the canonical 
conformation, the fifth EGF-like domain does not and possesses an alternate 
disulfide pairing of C1-C2, C3-C4, C5-C6. We examined the folding tendencies 
of two synthetic peptides corresponding to truncated versions of TM EGF-like 
domain four and five under air oxidation and redox folding conditions. By 
identifying the structural isoforms obtained in the folding reaction using 
regiospecifically-synthesized conformers as controls, we determined that the 
last segment of both domains (encompassing C5 and C6) do not influence the 
tendencies to fold into their respective native conformations.  When folded 
under denaturing conditions, the folding tendency of the fourth EGF-like 
domain changes to that of the C1-C2, C3-C4 conformer. Conversely, the 
addition of denaturant did not affect the folding tendency of the fifth EGF-like 
domain. This suggests that side chain interactions are crucial for achieving 
the canonical EGF-like domain fold but not for the non-canonical fold. Folding 
under high salt content did not disrupt the folding tendencies of both domains 
and result in slight increase of the C1-C3, C2-C4 conformer in both cases. This 
suggests that hydrophobic interaction, but not electrostatic interaction, is the 
key in the achieving the canonical fold of EGF-like domains.!
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1.1     The Protein Folding Problem!
Proteins obtain their native three-dimensional structure via folding from their 
primary structures. The question of how this folding is achieved is popularly 
known as the “protein folding problem”.  Although protein folding can be seen 
as a multifaceted problem, the questions involved can be summarized into 
primary aspects: (a) the folding code - the mechanistic question of how the 
primary amino acid sequence of a protein specifies its native three-
dimensional structure; (b) the folding pathway - the kinetic question regarding 
the route a protein take to reach its final native structure. 
 
1.1.1   The folding code 
Why do any two proteins, for example, lysozyme and ribonuclease, adopt 
different native three-dimensional structures? To do so, there must be a 
folding code that “instructs” each protein to fold into their respective native 
structures. What then is the nature of this folding code?  
As it is through the composite of different amino acid residues that 
differentiates one protein from another, one would see that the folding code is 
embedded in the amino acid side-chains located along the polypeptide chain. 
These side-chains provide folding instructions in terms of various inter-atomic 
forces (e.g. hydrophobic interactions, Van der Waals-interactions, electrostatic 
interactions, hydrogen bonding) mediated by the distinct physical-chemical 
properties of each side-chain.  
Thus, each amino acid, with its identity conferred by the nature of its side-
! +!
chain, can be perceived as a single “instructional unit” among others in the 
folding code. This relation is analogous to a statement in the source code of a 
computer program. From this viewpoint, the location of an amino acid residue 
in the sequence of a protein is, thus, equivalent to the logical placement of a 
statement among others in the source code. When a program file is being 
executed, an effect is produced as the computer carries out the instructions 
embedded in the sequence of statements of the source code. Analogously, 
the “execution” of the folding code will result in the folding of the polypeptide 
chain into its native structure based on the overall balance of inter-atomic 
forces dictated by the amino acid sequence.  
To this end, it became apparent that the amino acid sequence in guiding 
protein folding is also in itself the determinant of its native three-dimensional 
structure. Indeed, from the famous experiments on ribonuclease (RNase), 
Anfinsen and colleagues demonstrated that fully reduced RNase, which 
lacked demonstrable secondary or tertiary structure, could spontaneously 
refold in vitro using molecular oxygen to yield a product that is 
indistinguishable in terms of enzymatic activity from the native enzyme [1-3] 
(Figure 1.1). This result leads to the postulation that a protein#s native 
structure is its most thermodynamically stable structure, and the information 
needed for the assumption of such a structure, including the correct pairing of 
half-cystine residues in disulfide linkages, is determined by the amino acid 
sequence itself. This postulation is now known as the Anfinsen#s 
thermodynamic hypothesis and its conclusion provides the basis of studying 
native structures in isolation inside a test tube rather than inside cells.  
! %!
!
Figure 1.1   In vitro re-folding of ribonuclease. Reduced, denatured, ribonuclease can spontaneously 
refold into its native structure (with native disulfide-connectivity), upon the removal of denaturant (8M 
urea) and reducing agent ($-mercaptoethanol), via oxidative folding.  
 
Although Anfinsen#s thermodynamic hypothesis provides the apparent answer 
to the question of how proteins know a priori its native three-dimensional 
structure, the mechanistic details of how it works still remain elusive. Over the 
years, attempts to decipher the folding code had only lead to some general 
principles which are summarized below: 
(a) Secondary structure propensities ! 
Each of the 20 natural amino acids has different intrinsic properties to 
populate secondary structure elements. In fact, the frequencies with which 
different amino acids occur in "-helices and #-sheets of natural proteins 
correlate with the amino acid#s ability to stabilize these secondary 
structure elements [4]. Alanine, leucine, methionine and lysine have high 
propensities towards "-helices [5], whereas aromatic amino acids 
(tyrosine, phenylalanine and tryptophan) and #-branched amino acids 
(threonine, valine, isoleucine) have high propensities towards #-sheets 
[6]. Proline and glycine are not favored in "-helices and #-sheets and thus 
! '!
have the lowest propensities for both secondary structures.  
(b)  Binary patterning of polar and non-polar amino acids ! 
Hydrophobic interaction is considered one of the dominant forces in 
protein folding [7].  Thus, simple binary pattern of polar and non-polar 
residues along the polypeptide chain has been suggested to encode low-
resolution folding information which would give a protein its general 
topology [8]. In fact, Kamtekar et al. had demonstrated that de novo-
designed binary pattern of polar and non-polar amino acid residues was 
sufficient to encode four-helix bundle proteins [9]. In this seminal work, 
combinatorial methods were used to generate a large collection of amino 
acid sequences where individual positions in the sequence is specified as 
either polar or non-polar, but the precise identity of each residue is 
allowed to vary. The relatively simple information encoded in the  “binary 
code” is sufficient to generate a significant number of proteins that  fold  
into  compact  "-helical  structures.  
(c)  Complementary packing of amino acid side-chains ! 
If binary patterning of polar and non-polar amino acids is sufficient to 
specify the overall topology of the proteins, what then provide the 
information needed to generate the high-resolution structures of these 
proteins? These information come from the exact identities of the side-
chains that are “complementary packed” in the cores of proteins [8].   
In complementary packing, side-chains in the cores of proteins fit together 
without leaving any large cavities. They do so by maximizing hydrophobic 
! )!
contacts while avoiding any steric clashes that could occur. As the 
geometric requirement of complementary packing is dependent on the 
detailed properties of the side-chains involved (e.g. polarity, shapes, 
sized), the identities of core residues would, in turn, determine the 
protein#s high-resolution structure.  
The above discussion gave a simple and straightforward view on how the 
folding code is being interpreted. However, we should keep in mind that things 
are more complicated in reality as illustrated in the following examples: 
(a) Unlike "-helix propensity, #-sheet propensity of amino acids was later 
found to be context dependent [10]. The use of an edge strand rather than 
a center strand in the same #-sheet (of IgG-binding domain from protein 
G) for experimentation yielded a different scale of propensities.  
(b) In a related study, Minor and Kim successfully designed a so-called 
“chameleon” sequence that could fold as an "-helix when in one position, 
but as a #-sheet when in another position of the primary sequence of the 
IgG-binding domain of protein G [11]. This study demonstrated that the 
propensity of individual amino acids to form particular secondary 
structures is the result of intrinsic propensity, as well as, non-local 
interactions. In fact, a database survey of proteins with known three-
dimensional structures revealed many naturally occurring proteins with 
“chameleon” sequences [12].  
(c)  Short, disulfide-rich peptides such as the "-conotoxin family of neurotoxic 
peptides all fold into the same disulfide scaffold despite hypervariability of 
! ,!
the primary amino acid sequences [13] (Figure 1.2A). This hypervariability 
did not display any conservation of binary polar and non-polar amino acid 
patterns that was thought to determine the global topology of a protein 
fold. Since all members of the "-conotoxin family possess the same 
cysteine framework, it had been suggested that it was the identical 
cysteine pattern that contributed to the common fold. However, the related 
$/%-conotoxin family of neurotoxins also had the same cysteine 
framework, but they fold into an alternate disulfide scaffold (Figure 1.2B).   
 
!
Figure 1.2   Disulfide scaffold of !- and "-conotoxins. (A) Despite hypervariability of primary amino 
acid sequences, without conservation of binary polar and non-polar amino acid patterns, all "-
conotoxins fold into the same disulfide sca!old. (B) Despite identical cysteine patterns, "- and &-
conotoxins fold into distinct disulfide sca!olds. 
 
All the above examples tell us that there is still a large gap in our current 
understanding of the mechanism behind the interpretation of the folding code.  
Thus, the deciphering of the folding code still present an important field of 
! &!
research despite the continual emergence of successful protein design based 
on variants of existing proteins and broadened alphabets of non-natural amino 
acids [14]. 
 
1.1.2   The folding pathway 
In 1969, Cyrus Levithal formulated the well-known Levinthal#s paradox [15], a 
thought experiment which explained the requirement of a folding pathway. In a 
standard illustration of the thought experiment, the phi (') and psi (() angle of 
each amino acid residue in a polypeptide chain is assumed to have only 3 
possible conformations respectively. Accordingly, a 100-residue polypeptide 
chain will have a total of 198 phi/psi angles that is free to vary, resulting in a 
total of 3198 possible three-dimensional structures. If the polypeptide chain 
were to sample all possible structures at a rate of 1013 per second (or 3 ) 1020 
per year) before picking out the most thermodynamically stable structure to 
adopt, it would take approximately 1073 years for the 100-residue polypeptide 
chain to settle into its final structure. This time scale is more than astronomical 
if we were to take into consideration the fact that the Big Bang only occurred 
about 1.37 ) 1010 years ago.  However, the real paradox in this case lies in 
the empirical observation that small proteins such as the Engrailed 
Homeodomain protein [16] and cytochrome c [17] could fold on a microsecond 
to millisecond time scale.  
With such a short time scale, it is reasonable to postulate the existence of 
specific folding “route” that leads a polypeptide chain towards its native 
structure, thus allowing it to by-pass structures that are irrelevant or sub-
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optimal. To better understand this view, the following analogy could be used: 
Imagine you have to travel to London from Singapore for a business trip. If 
you do not have a definite path in mind, it will take you literally forever to reach 
London as you are just bumping around hoping to chance upon the English 
capital. However, if you have a definite itinerary, you could reach London in a 
matter of hours. What a difference in time-scale the presence of a defined 
pathway could make! 
The necessity of a protein folding pathway has led to intense research in this 
area. Examples of questions that have driven this field over the years are: 
Does the folding of a polypeptide chain proceed in a hierarchical manner? 
Does protein collapse to form compact non-native structures before actual 
structure formation? Does a folding nuclei exist? Does folding involve only a 
single distinct pathway or is multiple pathways possible?  
All these questions led to a multitude of possible solutions for the folding 
pathway puzzle. These include the “framework model”, “hydrophobic collapse 
model”, “nucleation-condensation model” and “energy landscape theory”. A 
brief description of each model is as follows: 
(a)  Framework model [18, 19] ! 
According to this model, a protein achieves its native structure in a 
stepwise manner, without the result of each step being re-considered at 
subsequent steps. Here, native secondary structures form before merging 
into a compact intermediate with a native-like structure. This is followed 
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by the formation of specific atomic interactions which will refine the tertiary 
structure of the protein.  
(b)  Hydrophobic collapse model [20, 21] ! 
In the hydrophobic collapse model, the polypeptide chain would first 
“collapse” into a more compact step before the initiation of secondary 
structure formation. The “collapse” is driven by the burial of hydrophobic 
side-chains due to the energetic stabilization conferred when they are 
sequestered from the surrounding water. This collapsed intermediate is 
also known as the “molten globule” and it is considered a “thermodynamic 
state” whose energy is lower than that of the denatured state but higher 
than that of the native state.  
(c)  Nucleation-condensation model [22-24] ! 
The nucleation-condensation model is an integration of the framework and 
the hydrophobic collapse model. The model describes a folding process 
which is analogous to crystal formation where an initial nucleation phase 
precedes outward crystal growth from the core. Here, a part of the 
polypeptide chain folds significantly earlier than other parts of the 
molecule, forming a nucleation site. This site, by initiating the first few 
correct secondary and tertiary structure interactions, then catalyzes 
further folding. From here, the folding reaction proceeds by having 
structure formation along the rest of the polypeptide chain which 
“condenses” or “collapses” onto the nucleation site, thus stabilizing the 
nucleus of the protein.  
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(d)  Energy landscape theory [25, 26] !  
Unlike other models of the protein folding pathway, the energy landscape 
theory assumes that folding occurs through organizing an ensemble of 
structures rather than through uniquely defined structural intermediates. 
Specifically, is a statistical description of a protein#s potential surface where a 
rugged funnel-like energy landscape biased the folding polypeptide towards 
its native structure. The mouth of the funnel represents the large entropy of 
the denatured state ! i.e. A large ensemble of denatured structures with high 
energy. As native/favorable contacts are formed, the stabilization energy will 
decrease with a concomitant drop in configurational entropy. This then pushes 
the folding polypeptide towards the single lowest energy structure which will 
become its native conformation.  
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1.2     Disulfide Bonds as Probes of Protein Folding 
1.2.1   Trapped disulfide-containing intermediates for the 
study of protein folding pathway 
Techniques such as fluorescence spectroscopy, pressure-jump relaxation, 
temperature-jump relaxation, hydrogen exchange pulse labeling and stopped-
flow circular dichroism had been used to study protein folding dynamics. 
Although these techniques allow the observation of protein folding events in 
the microsecond to millisecond timescale, they do not allow folding 
intermediates to be isolated for detailed characterization. This is due to the 
fact that folding intermediates are thermodynamically unstable and thus do 
not accumulate significantly at equilibration for them to be characterized. 
However, if these folding intermediates could somehow be trapped or “frozen” 
in time, it would offer a solution to the problem. To this end, disulfide bonds-
containing proteins had been suggested to be good candidates for detailed 
characterization of folding intermediates as they could be chemically trapped 
in the course of folding [27]. This is due to the unique chemistry of cysteine 
residues which are involved in disulfide bond formation. 
The folding of proteins containing disulfide bonds consist of two 
interdependent processes: (1) conformational folding and (2) disulfide bond 
regeneration [28]. During the course of conformational folding, two thiol 
groups (of cysteine residues) which are in close proximity to each other might 
form a disulfide bond via rearrangement (i.e. disulfide shuffling) or oxidation 
(e.g. air oxidation). Any free thiols present in the protein at this time could be 
chemically modified by iodoacetamide to prevent further disulfide bond 
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generation and thus conformational folding [29]. Another way to pause 
oxidative folding is by acid trapping ! To acidify the folding solution to 
disfavor the deprotonation of thiols to thiolates, the active species involved in 
disulfide bond formation [30].  
Trapped disulfide-containing folding intermediates had been used to elucidate 
the folding pathways of bovine pancreatic trypsin inhibitor (BPTI) [31, 32], 
hirudin [33], epidermal growth factor (EGF) [34], leech carboxypeptidase 
inhibitor (LCI) [35], "-lactalbumin [36] and RNase A [37]. The folding 
pathways of these disulfide-rich proteins had provided supporting evidence for 
the existence of various pathways suggested by fast-kinetic studies ! For 
example: In BPTI, a limited number of native-like intermediates funnel the 
protein towards its native structure, thus making this kind of folding in line with 
the “framework model” where local interactions is important in guiding the 
protein through the hierarchic condensation of native-like elements. On the 
other hand, hirudin-like proteins fold through an initial stage of disulfide bond 
formation followed by the rearrangement of isomers to form the native protein, 
thus making this kind of folding in line with the “hydrophobic collapse model” 
where an initial stage of collapse is followed by a slower annealing phase in 
which specific interactions are used to refine the structure [38]. 
 
1.2.2   Disulfide-connectivity based structural isoforms for the 
study of protein folding code    
In Section 1.1.2, we concluded that the absence of a folding pathway would 
require a 100-residue polypeptide chain to sample through 3198 possible 
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conformations (if each !- and "-angle is given 3 degrees of freedom) to find 
its native conformation. However, this is on the assumption that no cysteine 
residues, which could potentially participate in disulfide bonds, is present. Due 
to the structural constraint conferred by disulfide bonds, the inclusion of 6 
cysteine residues in the amino acid sequence of the polypeptide chain (i.e. 6 
cysteines, 94 non-cysteines) will make 3 disulfide bonds (if fully oxidized), 
resulting in the reduction of possible conformations to only 15. A 
conformational space of 3198 versus 15 makes a 93 order of magnitude 
difference! Even if it contains 17 disulfide bonds, the conformational 
possibilities of 6.33 ) 1018 will still be 76 order of magnitude lower than 
without any disulfide at all. Thus, the formation of disulfide bonds, whether 
native or non-native, during the process of protein folding is another 
innovative way to minimize the conformational search of a polypeptide chain.  
The presence of non-native disulfide bonds in folding intermediates seemed 
peculiar. However, it is not ! Instead of directing folding in the wrong 
direction, structural constraints imposed on the folding intermediates by non-
native disulfide bonds had been suggested to enhance the folding process by 
creating a compact fold, thus bringing other cysteine residues and different 
parts of the polypeptide chain into close proximity to facilitate the re-shuffling 
of disulfide bonds and the concomitant formation of the native structure, 
respectively [39].  
However, to guarantee the success of this useful strategy, nature must place 
sufficient information in the protein folding code to ensure that the disulfide-
connectivity is correct at the end of the folding process. If not, structural 
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constraint exerted by incorrect disulfide-connectivity might “lock” the protein 
into an incorrect conformation, thus negating any positive effects the 
formation of disulfide bonds have on the folding process.  
The presence of such information in the protein folding code is exemplified in 
in vitro oxidative folding experiments using atmospheric oxygen as the 
oxidizing agent. Unlike the use of redox buffer system, such as 
cysteine/cystine or reduced/oxidized glutathione, where disulfide bonds could 
be continually reduced then re-formed, cysteine oxidation by atmospheric 
oxygen goes through free radical intermediates [40] which is irreversible once 
all thiol groups available had been engaged in disulfide bonds (i.e. no disulfide 
shuffling). In spite of this, fully reduced proteins or peptides such as 
ribonuclease [1-3] and "-Conotoxin ImI [41] respectively, had been shown to 
recover their native disulfide-connectivity in reasonable yield upon re-oxidation 
by atmospheric oxygen. These results demonstrated that information for 
correct disulfide-connectivity is encoded in the primary amino acid sequence 
of the protein itself (as anticipated by Anfinsen#s thermodynamic hypothesis) 
and the “instructions” given by them is needed to form native disulfide bonds 
in the presence of other highly competitive oxidative processes.  
In view of the above discussion, one can see that the dictation of correct 
disulfide-connectivity is an integral part of the protein folding code. Thus, it is 
important for us to understand how this information is being embedded in the 
amino acid sequence of a protein. A good model to use for the understanding 
of native disulfide-connectivity determination is that of short peptides 
containing four cysteine residues. By careful manipulation of sequence 
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information and/or oxidative folding conditions, one could pick out structural 
determinants that influence the disulfide-connectivity choices. The limited 
subset of structural isoforms in these simple models (i.e. 3 isoforms for 2 
disulfide bonds) allows us to see the influence of minor manipulations on 
folding tendency quantitatively.  
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1.3     The Canonical Fold of the EGF-like domain 
In light of the gaps still present in our knowledge of the protein folding code 
(Section 1.1.1), this study was undertaken to provide more insights into this 
aspect of the protein folding problem. To this end, the canonical fold of the 
evolutionarily conserved epidermal growth factor (EGF)-like domain was 
chosen as the subject of our study.  
 
1.3.1   Description of the canonical EGF-like domain fold 
The EGF-like domain is a sequence of about 30 to 40 amino acid residues, 
with the epidermal growth factor itself being the prototype sequence [42] 
(Figure 1.3A). A notable feature of all EGF-like domains is the evolutionary 
conservation of six cysteine residues in defined positions along the amino 
acid sequence as well as a glycine and aromatic residue in the third inter-
cysteine region (Figure 1.3B).   
With regards to the secondary and tertiary structure of the canonical EGF-like 
domain, it folds into a three-looped structure made up of a central two-
stranded #-sheet followed by a loop to a short C-terminal two-stranded sheet 
(Figure 1.4). This structure is stabilized by three disulfide bonds formed 
between the first and third, second and fourth, fifth and sixth cysteine residue 
(C1-C3, C2-C4, C5-C6)1 of the domain.  
!
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
.! !Annotation of disulfide-connectivity: “C” denotes a cysteine residue. Number in subscript represents the relative 
position of the cysteine residue along the amino acid sequence from the N-terminal to C-terminal ! e.g. “1” means 
first cysteine residue, “2” means second cysteine residue, “3” means third cysteine residue, etcetera.! ! “-” (Dash) 
denotes the connectivity between the two indicated cysteine residues. !
! .&!
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Figure 1.3   The consensus sequence of the EGF-like domain. (A) The epidermal growth factor 
serves as the prototype sequence of the EGF-like domain. Its disulfide-connectivity is indicated by 




Figure 1.4   The canonical fold of the EGF-like domain. It consist of 3 loops, labeled as loop A, loop 
B and loop C, respectively. Cysteine residues are numbered according to their relative position along 
the amino acid sequence from the N-terminal to C-terminal.  The three disulfide bridges are also 
indicated. 
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1.3.2   Significance of studying the protein folding code of 
EGF- like domain   
EGF-like domains are found in the extracellular domain of membrane-bound 
proteins or in secreted proteins. They have been the subject of many 
biological investigations because it is an evolutionarily conserved protein 
domain with diverse functions !!For example, EGF-like domains from various 
proteins had been shown to be capable of: (a) Mediating receptor-binding for 
host-cell recognition in parasitic infection [43] ; (b) Conferring functional 
differences (activator or inhibitor) to various ligands involved in receptor 
signaling during embryogenesis [44] ; (c) Binding to calcium ions2 which 
serves to orient neighboring modules relative to each other in a manner that is 
required for biological activity (e.g. factor IX ! Gla-EGF fragment) [45]. Of 
course, the above-mentioned functions are only a tiny fraction of the vast 
functional capabilities of the EGF-like domains, but as this aspect of EGF-like 
domain biology is beyond the scope of this thesis, a detailed description shall 
not be attempted.  
However, of considerable interest in our discussion here is how do protein 
domains like the EGF-like domains achieve such an array of functional 
diversity? One reasonable explanation would be that of domain duplication 
during evolution, followed by accumulated amino acid changes in the 
duplicated domain to generate functional diversity. Indeed, functional 
divergence of the EGF-like domain had lead to hypervariability of amino acid
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
2 Constitute a distinct subset of EGF-like domain. The consensus sequence for  calcium binding is D/N-x-D/N-E/Q-y-
D/N-y-Y/F, where x indicates a variable amino acid and y indicates a sequence of variable amino acids.  
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sequence in its inter-cysteine region.  
Despite sequence hypervariability, most EGF-like domains (based on those 
with structures solved) fold into the canonical three-looped structure that is 
defined by a disulfide-connectivity of C1-C3, C2-C4, C5-C6 (Figure 1.4). For this 
to be possible, the perseverance of folding information in the amino acid 
sequence is necessary while functional evolution is taking place. However, the 
exact nature of this folding information is currently unknown ! Among the 30 
to 40 amino acid residues of the EGF-like domains, which are the “functional” 
residues and which are the “structural” residues? The “structural” residues 
constitute the protein folding code and they dictate the native three-
dimensional structure of the domain. This view slightly deviates from the 
traditional concept of the protein folding code in which the amino acid 
sequence in its totality determine the native structure of the protein. Here, only 
structural determinants are needed and they are interspersed in the amino 
acid sequence together with residues needed for the functional capability of 
the protein. This way of organizing “structure-function” information in the 
amino acid sequence allows for functional diversity to develop on a single 
protein scaffold. 
Here, the study of the folding code of the canonical fold of the EGF-like 
domain serve as a good starting point to provide more insights into the nature 
of structural determinants ! What are they, where are they located in the 
amino acid sequence and the mechanism by which they act. The focus of this 
study would be at the level of disulfide-connectivity as it is this aspect of the 
EGF-like domain structure that is most conserved despite slight variation in 
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the structure of the inter-cysteine loops3. In the case of EGF-like domain, the 
conservation of disulfide-connectivity had also led to the conservation of the 
overall fold, thus the study of the disulfide-connectivity is in itself a useful 
probe to understand the folding code of this domain.  
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
3 Slight variation in the structure of the inter-cysteine loops is inevitable due to the hypervariability of amino acid 
sequence in these regions of the EGF-like domains. However, it is important to note that only exact structural 
details are affected, while the overall three-looped structure is maintained throughout all EGF-like domains. 
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1.4     Thrombomodulin and Its Role in the Anti-
coagulation Pathway 
To determine the structural determinants that dictate the canonical fold (i.e. 
disulfide-connectivity) of the EGF-like domain, the fourth and fifth EGF-like 
domain of thrombomodulin (TM) were chosen as models for the study.  
Here, the role of TM in the anti-coagulation pathway will be discussed to aid in 
the understanding of the structural significance regarding it smallest co-factor 
active fragment ! TM EGF-like domain 4 and 5. 
 
1.4.1   TM as a regulator of the coagulation cascade 
1.4.1.1  Thrombin: The coagulant  
During secondary hemostasis, proteins in the blood plasma, called 
coagulation factors, engage in a complex pathway to form a fibrin meshwork. 
The purpose of this fibrin meshwork is to strengthen the platelet plug, which is 
formed during primary hemostasis, at the site of blood vessel injury.  
Thrombin, also known as coagulation factor II (FII), is a serine protease which 
acts as the direct effector in the formation of the fibrin meshwork. It does so in 
two steps: First, by converting fibrinogen into fibrin [46, 47] with the 
concomitant self-polymerization of fibrin monomers [48-50]. Second, by 
activating factor XIII (FXIII) into FXIIIa [51] which is responsible for the 
covalent cross-linking of the established fibrin-polymer [52]. 
In addition to its direct effects on fibrin meshwork formation, thrombin has the 
ability to amplify its own generation via the activation of other coagulation 
factors. Thrombin does so by activating: 
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(a) Factor XI (FXI) into FXIa [53] which, in turn, activates factor IX (FIX) into 
FIXa [54]. 
(b) Factor VIII (FVIII) into FVIIIa [55] which, in turn, acts as a cofactor for FIXa 
[56]. Together, they form the intrinsic tenase complex which activates 
factor X (FX) into FXa [57].  
(c) Factor V (FV) into FVa [58] which, in turn, acts as a cofactor for FXa [59]. 
Together, they form the prothrombin complex which activates prothrombin 
into thrombin, resulting in a positive feedback loop.   
 
1.4.1.2  Thrombin-TM complex: The anti-coagulant 
Although thrombin is an effective coagulant, this function could be reversed by 
the binding of TM, a transmembrane glycoprotein expressed on the luminal 
surface of vascular endothelial cells, in a 1:1 stoichiometric complex. By 
acting as a cofactor, TM serves as a molecular switch that turns thrombin into 
an anti-coagulant [60, 61].  
The thrombin-TM complex exerts its anti-coagulant activities in two main 
ways: (a) Passively, by preventing the binding of thrombin#s pro-coagulant 
substrates (fibrinogen, FV and FVIII [62-65]) ; (b) Actively, by the activation of 
protein C [66] which is a serine protease like thrombin. When protein C is 
activated by the thrombin-TM complex, it goes on to inactivate FVIIIa (with 
protein S and intact FV as cofactors) and FVa (with protein S as cofactor) [67-
69], thus shutting down the thrombin-mediated positive feedback loop on its 
own activation, and the reduction in formation of fibrin from fibrinogen.  
From the above discussion, we can see that TM plays a central role in the 
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homeostasis of the blood coagulation system by making thrombin a pivoting 
factor between pro-coagulation and anti-coagulation. Indeed, the importance 
of TM in the blood coagulation system could be exemplified by arterial and 
venous thrombotic diseases caused by mutations in the TM gene which 
resulted in the reduced expression of the TM protein [70]. In addition, effects 
of TM gene mutation could also be seen at the at level of embryonic 
development ! Isermann et al. showed that disruption of the mouse TM gene 
led to embryonic lethality due to activation of the blood coagulation at the feto-
maternal interface which resulted in the death of trophoblast cells [71].  
 
1.4.2   Structure-function relationship of TM: Role of the 
fourth to sixth EGF-like domains 
TM is a multi-modular protein consisting of a lectin-like domain at the amino 
terminal, followed by a hydrophobic segment, six tandem EGF-like domains, 
an O-glycosylated serine/threonine-rich domain, a trans-membrane segment 
and a short cytoplasmic tail (Figure 1.5). 
The smallest cofactor active fragment of TM had been identified as the fourth 
and fifth EGF-like domains. Together they constitute 10% of the specific 
activity of TM which is greatly enhanced when the sixth EGF-like domain is 
included [72]. Studies involving the individual EGF-like domain that constitute 
the cofactor active fragment had given us useful insights into the function of 
each specific domain:  
The fourth EGF-like domain (TM EGF D4) alone did not display any cofactor 
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Figure 1.5   The domain organization of thrombomodulin. 
!
activity when assayed as a replacement for full-length TM in protein C 
activation assay. It also did not display any ability to bind to thrombin when 
assayed as a competitive inhibitor for protein C activation when full-length TM 
is included in the reaction [73]. On the other hand, a TM fragment consisting 
of the fifth and sixth EGF-like domain (TM EGF D5-D6) was shown to bind to 
thrombin with high affinity by being a competitive inhibitor of thrombin-TM in 
the activation of protein C. However, like TM EGF D4, this fragment alone did 
not any cofactor activity [74]. These results support the view that although TM 
EGF D5 and TM EGF D6 could bind to thrombin, it needs TM EGF D4 for 
cofactor activity. Meanwhile, TM EGF D4 could not exert its function as it 
could not associate with thrombin without the help of TM EGF D5-D6. Further 
support for the central role of TM EGF D4-D6 in TM#s function comes in terms 
of structural evidence provided by Fuentes-Prior et al. [75]: 
In a 2.3 Å crystal structure of human "-thrombin bound to the TM EGF D4-D6 
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fragment (Figure 1.6), it was demonstrated that TM EGF D5 and part of TM 
EGF D6 bind to a cluster of lysine and arginine residues in the anion-binding 
exosite-I of thrombin. Since thrombin#s procoagulant substrates like 
fibrinogen, FV and FVIII also bind to thrombin via exosite-I [62-65], the 
competitive binding of TM EGF D5-D6 segment to the same site provides the 
basis of blockade of procoagulant substrates in the thrombin-TM complex.  
!
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Figure 1.6   Ribbon model of the complex between !-thrombin and TM EGF D4-D6 [PDB: 1DX5]. 
"-Thrombin is shown in white. TM EGF D4, TM EGF D5 and TM EGF D6 are shown in cyan, yellow and 
red, respectively. Disulphide linkages are shown in green. 
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On the hand, the TM EGF D4 segment was shown to be anchored almost 
perpendicular to the linear TM EGF D5-D6 tandem. It protrudes away from 
thrombin, and thus does not interact directly with it. It was suggested that 
thrombin binding to the TM EGF D5-D6 segment creates an additional 
substrate-binding interface on TM EGF D4-D5. The “free” TM EGF D4 
segment is then needed to interact with anti-coagulant substrates of thrombin 
(i.e. protein C) such that it positions the scissile peptide bond of the substrate 
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with the catalytic machinery of thrombin in an optimal stereochemical 
conformation for cleavage. This interaction provides the structural basis for 
the alteration of thrombin#s substrate specificity upon TM#s binding. 
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1.5     Thrombomodulin EGF-like Domain 4 and 5: 
          Models in the Study of the EGF-like Domain Folding Code 
 
1.5.1   TM EGF D4 versus TM EGF D5: Canonical versus non-
canonical EGF-like domain fold 
As TM EGF D4-D5 is the smallest active cofactor of TM, there had been keen 
interest in solving the three-dimensional structure of these two domains as 
part of a larger effort to understand the structure-function relationship of TM. 
The results of these research had led to the discovery of a non-canonical 
EGF-like domain fold involving TM EGF D5 [76-78]. This non-canonical 
structure of EGF-like domain is defined by a different disulfide-connectivity, 
and thus, is of considerable interest in this current study regarding the folding 
code of the canonical EGF-like domain. Below will be a brief description of the 
structure of TM EGF D4 and D5 with the intent to highlight the key differences 
between these two domains with regards to their three-dimensional structure.  
 
1.5.1.1   Solution structure of TM EGF D4 
The solution structure of human TM EGF D4 has been determined by 2D 1H 
NMR [73, 79]. Here, the overall structure resembles that of the canonical 
EGF-like domain. Residues that are important for cofactor activity (Glu357, 
Tyr358, Gln359, Glu374 and Phe376), as determined by alanine scanning 
experiments, are found to form a “patch” that is exposed to solvent in the 
structure of TM EGF D4 [73]. More importantly (due to the purpose of this 
study), TM EGF D4 possesses the canonical EGF-like domain disulfide-




Figure 1.7   Solution structure of TM EGF D4 and its disulfide-connectivity. (A) Backbone structure 
of TM EGF D4 (white) [PDB: 1DQB]. Disulfide linkages are indicated in yellow. Locations of cysteine 
residues are labeled as C1, C2, C3, C4, C5 and C6. (B) The amino acid sequence of TM EGF D4 with 
disulfide-connectivity indicated. The disulfide-connectivity of TM EGF D4 is C1-C3, C2-C4, C5-C6. This is 
the disulfide-connectivity of the canonical EGF-like domain. 
!
1.5.1.2   Solution structure of TM EGF D5 
Like TM EGF D4, the structure of human TM EGF D5 has also been 
determined by 2D 1H NMR [76, 79]. The structure of this domain appears to 
have diverged from the canonical EGF-like structure ! The central two-
stranded #-sheet in the canonical EGF-like domain is absent in TM EGF D5. 
Furthermore, the N- and C-termini is closer together in TM EGF D5 than in 
other EGF-like domains. In addition to structural divergence from the 
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canonical EGF-like fold, it is important to note that TM EGF D5 also possess a 
novel disulfide-connectivity of C1-C2, C3-C4, C5-C6 (Figure 1.8). 
 
!
Figure 1.8   Solution structure of TM EGF D5 and its disulfide-connectivity. (A) Backbone structure 
of TM EGF D5 (white) [PDB: 1DQB]. Disulfide linkages are indicated in yellow. Locations of cysteine 
residues are labeled as C1, C2, C3, C4, C5 and C6. (B) The amino acid sequence of TM EGF D5 with 
disulfide-connectivity indicated. The disulfide-connectivity of TM EGF D4 is C1-C2, C3-C4, C5-C6. This 
disulfide-connectivity is non-canonical. 
The functional significance of this unique non-canonical structure (and 
disulfide-connectivity) can be seen from a series of experiments performed by 
Meininger, Hunter and Komives [78]. In these experiments, various structural 
isoforms of TM EGF D5, based on differential disulfide-connectivity, were 
tested for thrombin-binding affinities through two kinds of thrombin inhibition 
assays ! (a) Amount of peptide needed to double fibrinogen clotting time 
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(thrombin inhibition) and (2) inhibition of protein C activation (competition with 
native full-length TM for thrombin binding). Key results from these two assays 
are highlighted below (Table 1.1):  
!
Table 1.1!!!Effect of various TM EGF D5 structural isoforms on thrombin activity!
TM EGF D5 
Structural Isoform 
Amount of peptide to double 
clotting time 
(*M) 
Ki for protein C 
activation 
(*M) 
C1-C2, C3-C4, C5-C6 210 ± 50 370 ± 50 
C1-C3, C2-C5, C4-C6 340 ± 50 830 ± 50 
[xt] C1-C2, C3-C4, C5-C6 0.2 ± 0.02 1.9 ± 0.2 
[xt] C1-C3, C2-C4, C5-C6 9 ± 1 13 ± 1 
Note. Structural isoforms are defined by disulfide-connectivity. [xt] denotes an extended form of the TM 
EGF D5 isoform which included four additional amino acids connecting the fifth and sixth EGF-like 
domains of TM. Adapted from “Thrombin-binding affinities of different disulfide-bonded isomers of the 
fifth EGF-like domain of thrombomodulin,” by M.J. Hunter and E.A. Komives, 1995, Protein Science, 4, 
p. 2134.  
From these results, it is apparent that the C1-C2, C3-C4, C5-C6 isoform of TM 
EGF D5 is a better inhibitor of thrombin activity and thrombin-TM interaction 
than the C1-C3, C2-C5, C4-C6 isoform. This is because a lower amount of C1-
C2, C3-C4, C5-C6 isoform is needed to achieve comparable inhibition level in 
both assays. Moreover, for the extended isoforms of TM EGF D5, which 
included four additional amino acids from the linker region between TM EGF 
D5 and TM EGF D6 (for the purpose of better binding), the [xt] C1-C2, C3-C4, 
C5-C6 isoform could inhibit both thrombin activity and thrombin-TM interaction 
better than the [xt] C1-C3, C2-C4, C5-C6 (canonical EGF-like domain) isoform. 
Therefore, the non-canonical structure/disulfide-connectivity of TM EGF D5 
has a high structure-function significance. This indicates that this highly 
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divergent EGF-like domain had been evolutionarily selected for, and is not 
simply a neutral mutation which has been “accidentally” preserved.  
 
1.5.2   TM EGF D4 and TM EGF D5 as models to identify the 
structural determinants of the canonical EGF-like 
domain fold   
Due to the different nature of TM EGF D4 and D5 with respect to their 
structure (i.e. TM EGF D4 is canonical EGF-like, while TM EGF D5 is non-
canonical), they serve as contrasting models in the study of the EGF-like 
domain folding code. Moreover, since the structural divergence of TM EGF D5 
had been evolutionarily selected for, it also serves as an interesting model to 
show how structural divergence can be achieved within a single domain.  
In the context of our study, the different native disulfide-connectivity of TM 
EGF D4 and TM EGF D5, with corresponding difference in structures, serve 
as a useful tool for the identification of structural determinants in the canonical 
EGF-like domain (C1-C3, C2-C4, C5-C6) fold. The criteria for being the 
structural determinants based on these two contrasting models are: 
(a) The amino acid qualifying as the structural determinant of TM EGF D4 
should not be present at its equivalent position in TM EGF D5, and vice 
versa.  
(b) When the structural determinant of TM EGF D4 is replaced with another 
residue of different physical-chemical property, it should change its folding 
tendency to that of the non-canonical fold.  
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(c) When TM EGF D4#s structural determinant is placed into its equivalent 
position in TM EGF D5, it should increase TM EGF D5#s folding tendency 
towards that of the canonical EGF-like domain fold.  
These criteria are based on the hypothesis that the switch from the canonical 
C1-C3, C2-C4 conformer to the non-canonical C1-C2, C3-C4 conformer is the 
result of a change in the physical-chemical properties of the canonical fold#s 
structural determinants. The change in physical-chemical properties of the 
structural determinants will then be manifested as a change in the dominant 
force of folding, thus resulting in a different final structure and disulfide-
connectivity. Therefore, studies that quantify the relative contribution of 
various inter-molecular forces to the folding tendencies of both domains would 
provide the clue to the nature and identity of the structural determinants. 
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1.6     Objectives and Scope of the Thesis 
The main objective of this thesis is to identify structural determinants that are 
responsible for dictating the alternate disulfide-connectivity of TM EGF D4 and 
TM EGF D5. The scope of this thesis covers the following areas:  
(a) General localization of the structural determinants in TM EGF D4 and D5. 
More specifically, it is to find out whether their respective structural 
determinants are located locally within the segment encompassing C1 to 
C4 (where disulfide-connectivity difference of TM EGF D4 and D5 lies) or if 
the C-terminal segment of the domain  (encompassing C5 to C6) has a role 
in influencing the different disulfide-connectivity preference of the front 
segment.  
(b) Determination of the dominant force that dictates the folding tendency/ 
disulfide-connectivity preference of each domain (i.e. hydrophobic or 
electrostatic). 
(c) Identification of key residues as structural determinants in TM EGF D4 and 
D5. This would be aided by knowledge regarding the general localization 
of the structural determinants and the nature of the dominant force that 
drive their respective folding tendencies.  
 




2.1     Peptide Synthesis and Purification 
2.1.1   Peptide synthesis 
Peptides were synthesized using manual 9-fluorenylmethoxycarbonyl (Fmoc)-
solid phase peptide synthesis. All amino acids used were Fmoc-L-(amino 
acid)-OH derivatives, with some residues containing side-chain protection 
groups. The side-chain protected amino acids used were: Arg(Pbf), Asn(Trt), 
Asp(OtBu), Cys(Trt), Cys(Acm), Gln(Trt), Glu(OtBu), His(Trt), Ser(tBu), 
Thr(tBu), and Tyr(tBu). For synthesis of truncated TM EGF D4 and D5 
structural isoforms (t-TM EGF D4 and t-TM EGF D5), Cys(Trt) and Cys(Acm) 
were incorporated at specific locations along the amino acid sequence ! (a) 
C1: Cys(Trt), C2: Cys(Acm), C3: Cys(Trt), C4: Cys(Acm) for C1-C3, C2-C4 
isoform ; (b) C1: Cys(Trt), C2: Cys(Trt), C3: Cys(Acm), C4:  Cys(Acm) for C1-
C2, C3-C4 isoform ; (c) C1: Cys(Acm), C2: Cys(Trt), C3:   Cys(Trt), C4: 
Cys(Acm) for C1-C4, C2-C3 isoform (Figure 2.1). For peptides used for in vitro 
oxidative folding experiments, only Cys(Trt) was used.  
The peptides were assembled on the Novasyn® TGR resin (Novabiochem, 
Darmstadt, Hesse, Germany), which was designed for the synthesis of 
peptide amides. The coupling step was performed in N,N-dimethylformamide 
(DMF): N-Methyl-2-pyrrolidone (NMP) (2:1) with 5 times excess of amino acid 
derivatives activated in situ by 4.9 times excess of O-(7-Azabenzotriazol-1-yl)-
N,N,N!,N!-tetramethyluronium hexafluorophosphate (HATU) and 10 times 
excess of N,N-diisopropyl-ethylamine (DIPEA). Removal of Fmoc-moiety (de-
blocking) was achieved using a solution of 20% (v/v) piperidine in DMF. The 
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success of coupling and de-blocking was verified for each residue using the 
Kaiser test [80] (all amino acid residues except Pro) and Chloranil test [81] 
(Pro residue).  
!
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Figure 2.1   Synthesis of t-TM EGF D4 and t-TM EGF D5 structural isoforms and their respective 
"test peptides" using Cys(Acm) and Cys(Trt). For the synthesis of structural isoforms, Cys(Trt) and 
Cys(Acm) were incorporated at specific positions along the polypeptide chain as illustrated in: (A) C1-C3, 
C2-C4, (B) C1-C2, C3-C4, and (C) C1-C4, C2-C3. (D) For the synthesis of peptides used for in vitro 
oxidative folding experiments, only Cys(Trt) was used. 
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2.1.2   Peptide cleavage, deprotection and isolation 
After synthesis was complete, the resin was rinsed extensively with 3 cycles 
of successive methanol (MeOH), DMF and dichloromethane (DCM) washes, 
followed by a final MeOH rinsing step before drying overnight under vacuum. 
Peptides without Cys(Acm) derivatives were deprotected and cleaved from 
the resin using a cocktail of trifluoroacetic acid (TFA)/1,2-ethanedithiol 
(EDT)/thioanisole/water (90:4:4:2 % v/v) for 2 hrs with gentle stirring. Peptides 
with Cys(Acm) derivatives were deprotected and cleaved from the resin with a 
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cocktail of TFA/EDT/triisopropylsilane (TIS)/water (94:2.5:1:2.5 % v/v) instead.  
After removal of the resin by filtration through fritted glass funnels, the 
peptides were precipitated by dropping the filtrate drop-wise into ice-cold 
diethyl-ether. The precipitate was collected as a pellet after centrifugation and 
allowed to dry overnight. 
 
2.1.3   Peptide purification 
Dried peptides were dissolved using 0.1% (v/v) TFA in 10% (v/v) acetonitrile 
(ACN) and purified using reversed-phase HPLC with a Jupiter Proteo, 4 *, 90 
Å (15 ) 250 mm) column (Phenomenex, Torrance, California, USA) on an 
ÄKTA™ purifier system (GE Healthcare, Uppsala, Sweden). A segmented 
gradient elution method involving TFA as the counter-ion (constant 
concentration of 0.1% v/v), and ACN as the organic modifier (maximum 80% 
v/v) was used. The purified peptides were verified using electrospray 
ionization-mass spectrometry (Section 2.1.4) before lyophilization.  
 
2.1.4   Electrospray ionization-mass spectrometry (ESI-MS) 
Peptide mass determination using ESI-MS was performed on an API-300 
LC/MS/MS system (Perkin-Elmer Sciex, Selton, Connecticut, USA). The 
samples were introduced via direct injection. The LC-10AD liquid 
chromatography system (Shimadzu, Kyoto, Japan) was used as the solvent 
delivery system with 0.1% (v/v) formic acid in 50% ACN as the solvent. 
Ionspray, orifice and ring voltages were set at 4600 V, 50 V and 350 V, 
respectively. Nitrogen was used as the nebulizer and curtain gas. 
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2.2     Regioselective Synthesis of Structural Isoforms 
By placing S-trityl (Trt) or S-acetamidomethyl (Acm)-protected cysteine 
residues at specific positions along the peptide chain (Section 2.1.1), 
orthogonal protection of cysteine residues# side-chains were used to generate 
structural isoforms based on differential disulfide-connectivity. Cysteine 
residues involved in the formation of the first disulfide bridge were protected 
with the acid labile Trt-group, which were removed upon TFA treatment in the 
peptide synthesis cleavage step (Section 2.1.2). After formation of the first 
disulfide bridge, the remaining two Acm-protected cysteine residues would be 
treated with iodine to achieve simultaneous removal of Acm-group and 
oxidation to form the second disulfide bridge.  
 
2.2.1   Formation of the first disulfide bridge 
2.2.1.1  DMSO-mediated oxidation 
Fully reduced, purified Cys(Acm)-containing peptides with two free cysteine 
residues were dissolved at a concentration of 0.3 mM in a 0.1 M Tris-HCl, pH 
7.5 buffer containing 10% ACN and 20% DMSO. DMSO-mediated oxidation 
was allowed to take place under vigorous stirring and the progress of the 
reaction was monitored using the Ellman#s test (Section 2.2.1.2). When 
reaction was completed, as indicated by a negative Ellman#s test, the pH of 
the solution was adjusted to pH 2 using concentrated HCl. The peptide, now 
containing one disulfide-bridge, was directly injected into the Jupiter Proteo, 4 
*, 90 Å (15 ) 250 mm) column for purification using the segmented gradient 
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elution method described in Section 2.1.3. The purified peptides were verified 
using ESI-MS (i.e. mass reduction of 2 Da) before lyophilization.  
 
2.2.1.2  Ellman#s Test 
A reaction buffer of 0.1 M sodium phosphate, pH 8.0, containing 1 mM EDTA 
was prepared. This was followed by an Ellman#s reagent solution which was 
made by dissolving 5,5'-dithio-bis-(2-nitrobenzoic acid) (DTNB) in the reaction 
buffer at a concentration of 0.4% (w/v). The proportion of Ellman#s reagent, 
peptide sample and reaction buffer used in the test is 1:5:50, respectively. 
The reaction mixture was incubated at room temperature for 15 mins before 
the absorbance of the sample was measured at 412 nm using a NanoVue 
spectrophotometer (GE Healthcare, Uppsala, Sweden).  
 
2.2.2   Formation of the second disulfide bridge: Iodine 
mediated simultaneous deprotection/oxidation  
Purified Cys(Acm)-containing peptides with one disulfide bridge was dissolved 
at a concentration of 0.6 mM in a mixed solvent consisting of 10% (v/v) ACN 
and 80% (v/v) acetic acid. Solid iodine (5 equivalent per Acm) and HCl (1.5 
equivalent per Acm) were then added to the peptide solution. The reaction 
was allowed to proceed with vigorous stirring for 1 hr before quenching with a 
1 M ascorbic acid solution drop-wise until a colorless solution was obtained. 
The reaction mixture was diluted 4-fold before loading into the Jupiter Proteo, 
4 *, 90 Å (15 ) 250 mm) column for purification using the segmented gradient 
elution method described in Section 2.1.3. The purified peptides were verified 
using ESI-MS (i.e. mass reduction of 144 Da) before lyophilization.  
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2.3     Oxidative Folding of Fully Reduced Peptides 
2.3.1   Air oxidation 
The buffer used for air oxidation was 0.1 M Tris-HCl, pH 8.0, containing 10% 
(v/v) ACN. Fully reduced peptides (all cysteine residues derived from Cys(Trt) 
derivative) was dissolved at a concentration of 0.1 mM. The solution was 
stirred in an open atmosphere, and the progress of the reaction was 
monitored using the Ellman#s test (Section 2.2.1.2). When the reaction was 
completed (negative Ellman#s test), the pH of the solution was adjusted to pH 
2 using concentrated HCl. For air oxidation in the presence of denaturant, 6 M 
guanidine hydrochloride (Gn.HCl) was included in the buffer.  
 
2.3.2   Oxidation in the presence of redox reagents 
The buffer used for redox reagent-mediated oxidation was 0.1 M Tris-HCl, pH 
8.0, containing 1 mM EDTA, 2 mM reduced glutathione, 1 mM oxidized 
glutathione and 10% (v/v) ACN. Fully reduced peptides (all cysteine residues 
derived from Cys(Trt) derivative) was dissolved at a concentration of 0.1 mM. 
The solution was then purged with nitrogen gas for 5 mins before the reaction 
tube was sealed. The reaction was allowed to proceed with vigorous stirring 
for 48 hrs before the pH of the solution was adjusted to pH 2 with 
concentrated HCl. For redox reagent-mediated oxidation in the presence of 
denaturant or high salt content, 6 M Gn.HCl or 0.5 M NaCl was included in the 
buffer, respectively.  
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2.4     Chromatographic Separation of Structural Iso-
forms Obtained from Oxidative Folding Studies     
 
2.4.1   Structural isoforms of t-TM EGF D4 
Structural isoforms of t-TM EGF D4 obtained from oxidative folding (Section 
2.3) were separated using reversed-phase HPLC with a Cosmosil Cholester, 
5 *, 120 Å (4.6 ) 250 mm) column (Nacalai Tesque, Kyoto, Japan). A 
segmented gradient elution method involving TFA as the counter-ion 
(constant concentration of 0.1% v/v), and MeOH as the organic modifier 
(maximum 60% v/v) was used. 
  
2.4.2   Structural isoforms of t-TM EGF D5 
Structural isoforms of t-TM EGF D5 obtained from oxidative folding (Section 
2.3) were separated using reversed-phase HPLC with a Kinetex™ PFP, 2.6 *, 
100 Å (4.6 ) 100 mm) column (Phenomenex, Torrance, California, USA). A 
segmented gradient elution method involving heptafluorobutyric acid (HFBA) 
as the counter-ion (constant concentration of 10 mM), and MeOH as the 
organic modifier (maximum 80% v/v) was used. 
 
2.4.3   Structural isoforms of t-TM EGF D4 (Y25T) 
Structural isoforms of t-TM EGF D4 (Y25T) obtained from oxidative folding 
(Section 2.3) were separated using reversed-phase HPLC with a Cosmosil 
Cholester, 5 *, 120 Å (4.6 ) 250 mm) column (Nacalai Tesque, Kyoto, Japan). 
A segmented gradient elution method involving HFBA as the counter-ion 
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(constant concentration of 10 mM), and MeOH as the organic modifier 
(maximum 80% v/v) was used. 
 
2.4.4   Calculation of peak area 
The amount of each structural isoform obtained is correlated to the area of its 
corresponding peak in the chromatogram. The peak area was calculated 
using the “peak integration” function of the UNICORN protein purification 
software (GE Healthcare, Uppsala, Sweden). Skim procedures were applied 
when deemed necessary to improve accuracy of calculations. 
 
2.4.5   Statistical analysis 
All oxidative folding experiments were performed in triplicates. The amount of 
each structural isoform obtained from each replicate was expressed as 
percentage values before the average and standard deviation values were 
calculated. 
The Student#s t-test (independent samples) (Eq. 1 to Eq. 5, Table 2.1) was 
used to test for significant differences in the proportion of corresponding 
structural isoforms obtained from two different oxidative folding conditions. It 
should be noted that for a parametric test, the direct input of percentage data 
is not recommended. Thus, in accordance to a solution recommended by Zar 
[82], an arcsine transformation (Eq. 6, Table 2.1) was performed on all 




Student#s t-test (Independent samples) 
 
            (Eq. 1) 
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          (Eq. 3) 
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Arcsine transformation (degrees) 
 
         (Eq. 6) 
 
Table 2.1   Annotation for statistical formulas (Eq. 1 to Eq. 6) 
Student#s t-test (Independent samples) 
%x1 
mean of arcsine transformed values ! 
oxidative folding condition 1 
%x2 
mean of arcsine transformed values ! 
oxidative folding conditions 2 












standard deviation of arcsine transformed 
values ! oxidative folding condition 1 
s2 
standard deviation of arcsine transformed 
values ! oxidative folding condition 2 
n1 number of trials for oxidative folding condition 1 
n2 number of trials for oxidative folding condition 2 
Arcsine transformation 
x percentage value 
 
The p-values for the Pearson#s chi-square test were obtained using the “p-
value calculator for the chi-square test” ! http://www.danielsoper.com/ 
statcalc/calc11.aspx 
The p-values for the Student#s t-test (indepndent samples) were obtained 
using the “p-value calculator for the Student t-test” ! http://www.danielsoper. 
com/statcalc/calc08.aspx 
!Chapter 3: Results and Discussion 
!
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3.1     Synthesis of Truncated TM EGF D4 and TM EGF 
D5 Structural Isoforms 
To identity structural determinants in the 45- and 39-residue long domains of 
TM EGF D4 and TM EGF D5, respectively, it is important to simplify the 
search by narrowing down the region in which the determinants are located. 
Since the structural/disulfide-connectivity difference of TM EGF D4 and D5 
are restricted to the first two disulfide bonds within their N-terminal segments 
(encompassing C1 to C4) (Figure 3.1), it was of interest to determine whether 
the structural determinants of each domain are located locally within that 
segment or if the C-terminal segment of the domain (encompassing C5 to C6) 
had a role in influencing the different disulfide-connectivity preference of the 
front segment.  
 
!
Figure 3.1   A comparison between the disulfide-connectivity of (A) TM EGF D4 and (B) TM EGF 
D5. The difference in disulfide-connectivity lies in the first two disulfide bonds of the respective domains, 
as denoted by asterisks (*). The disulfide-connectivity of C1 to C4 is C1-C3, C2-C4 for TM EGF D4, while it 
is C1-C2, C3-C4 for TM EGF D5.   
!
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To do so, truncated version of TM EGF D4 and D5 (t-TM EGF D4 and t-TM 
EGF D5) lacking the segment encompassing C5 to C6 were used for in vitro 
oxidative folding studies. The structural isoforms obtained from these studies 
were identified by comparing and matching their retention volume with those 
of regioselectively-synthesized structural isoforms.  
These regioselectively-synthesized structural isoforms were generated using 
an orthogonal cysteine-protection scheme depicted in Figure 3.2 (details in 
Materials and Methods, Section 2.1 and Section 2.2). The retention volume 
and elution order of each individual structural isoform was then determined by 
reversed-phase HPLC on a Cosmosil Cholester column for t-TM EGF D4 
isoforms, and a Kinetex PFP column for t-TM EGF D5 isoforms (details in 
Section 2.4).  
 
3.1.1   Elution characteristics of t-TM EGF D4 structural 
isoforms 
Human t-TM EGF D4 has a sequence of “HMEPVDPCFRANCEYQCQPLNQT 
SYLCV”. The regioselective synthesis of t-TM EGF D4 structural isoforms 
were successful as the observed average mass of each isoform correspond 
well with the theoretical (fully oxidized) average mass of 3284.7 Da (Table 3.1 
and Appendix (AP) Figure A3.1 to A3.3): 
 
Table 3.1   Observed versus theoretical mass of t-TM EGF D4 structural isoforms 
Structural Isoform Observed  
Average Mass (Da)a 
Theoretical  
Average Mass (Da) 
C1-C3, C2-C4 (Native) 3284.69 
C1-C2, C3-C4 3284.68 
C1-C4, C2-C3 3284.72 
3284.7 
a Observed masses were calculated from ESI-MS data obtained from Perkin-Elmer Sciex API 300 





Figure 3.2   Regioselective synthesis of t-TM EGF D4 and t-TM EGF D5. In stage 1, the peptide chain was assembled by solid phase peptide synthesis on a rink amide-
based resin. Cysteine residues with S-trityl (Trt) or S-acetamidomethyl (Acm) side-chain protection groups were incorporated at specific locations along the peptide chain. Upon 
treatment with high concentration of TFA, the peptide chain was released from the solid phase with simultaneous removal of all side-chain protection groups except Acm-
groups on cysteine residues. In stage 2, the first disulfide bond was formed by DMSO-mediated oxidation of the two free cysteine residues previously derived from Cys(Trt). 
The second disulfide bond was formed by iodine treatment (at 5 equivalent per Acm) which mediated the simultaneous deprotection and oxidation of Cys(Acm) residues. 
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The elution order of t-TM EGF D4 structural isoforms based on reversed-
phase analysis using the Cosmosil Cholester column is as follows: C1-C3, C2-
C4 (native) (lowest retention volume), followed by C1-C2, C3-C4, and C1-C4, C2-
C3 (highest retention volume).  
As a gradual decrease in retention volume was observed with every use of the 
column (due to reasons yet unknown), each structural isoforms was re-
analyzed individually on the column with every set of oxidative folding 
experiments to re-establish the retention volume of each structural isoform. 
This is to ensure the validity of the retention volume-based identification of 
various structural isoforms even though the elution order of the isoforms was 
not affected (i.e. retention volume of each isoform decrease by the same 
factor, therefore, not affecting the order of elution).   
 
3.1.2   Elution characteristics of t-TM EGF D5 structural 
isoforms 
Human t-TM EGF D5 has a sequence of “MFCNQTACPADCDPNTQASCE”. 
The regioselective synthesis of t-TM EGF D5 structural isoforms were 
successful as the observed average mass of each isoform correspond well 
with the theoretical (fully oxidized) average mass of 2244.5 Da (Table 3.2 and 
AP Figure A3.4 to A3.6): 
 
Table 3.2!!!Observed versus theoretical mass of t-TM EGF D5 structural isoforms!





Average Mass (Da) 
C1-C3, C2-C4  2244.49 
C1-C2, C3-C4 (Native) 2244.45 
C1-C4, C2-C3 2244.51 
2244.5 
a
 Observed masses were calculated from ESI-MS data obtained from Perkin-Elmer Sciex API 300 
LC/MS/MS system using the “Peptide Reconstruct” function of the Analyst
®
 software.  
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The elution order of t-TM EGF D5 structural isoforms based on reversed-
phase analysis using the Kinetex PFP column is as follows: C1-C2, C3-C4 
(native) (lowest retention volume), followed by C1-C3, C2-C4, and C1-C4, C2-C3 
(highest retention volume).  
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3.2     The in vitro Folding Tendencies of t-TM EGF D4 
and t-TM EGF D5  
To determine the folding tendency of t-TM EGF D4 and t-TM EGF D5, fully 
reduced peptides with all free cysteine residues, were placed in high pH (pH 
8.0) buffer for in vitro oxidative folding. Two oxidative conditions were used: 
(a) Air oxidation, which makes use of atmospheric oxygen. Here, the oxidation 
process going through a series of free radical intermediates [40] and often 
results in cleaner products. However, the dominant product obtained may not 
represent the most thermodynamically favorable conformation; (b) Redox 
system, which involves the use of reduced:oxidized glutathione at a ratio of 
2:1. These compounds catalyze disulfide exchange reactions resulting in the 
most thermodynamically favorable status of the cysteine residues [83]. 
However, it has the disadvantage of generating additional products which 
corresponds to peptides containing intermolecular disulfides between the 
peptide and glutathione [84].  
 
3.2.1   In vitro oxidative folding of t-TM EGF D4 
Oxidative folding of reduced t-TM EGF D4 was performed using air oxidation 
and redox reagent-mediated folding: 
(a)  Air oxidation-mediated folding of reduced t-TM EGF D4 was monitored by 
the Ellman!s test and the reaction was deemed complete when a negative 
test result was obtained. For t-TM EGF D4, the completion of oxidative 
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reaction were resolved by reversed-phase chromatography and as 
expected, three monomeric isoforms were obtained (Figure 3.3).  
(b)  Redox reagent-mediated folding of t-TM EGF D4 was allowed to proceed 
for 48 hrs before the reaction was quenched by acidification. Like air 
oxidation, three monomeric isoforms were obtained (Figure 3.4).  
In both cases, the retention volume of the three monomeric isoforms obtained 
matched well with that of regioselectively-synthesized structural isoforms. This 
enabled the identification of peaks in the chromatogram, and the relative 
proportions of the three isoforms were calculated based on the area of their 
respective peaks (Table 3.3A: Purple columns). 
Results from both oxidative folding experiments showed that t-TM EGF D4 
has a folding preference towards the C1-C3, C2-C4 (native) isoform as it 
constitutes the highest percentage of t-TM EGF D4 structural isoforms 
obtained in both cases. 
Pairwise comparison of corresponding structural isoforms from air oxidation 
and redox reagent-mediated oxidation studies using Student!s t-test (with 
arcsine transformed-percentage values) showed significant differences (at 
0.05 level of significance) in the proportions of C1-C3, C2-C4 (native) and C1-
C2, C3-C4 structural isoforms obtained between the two studies. Here, an 
increase and decrease in the proportion of C1-C3, C2-C4 (native) and C1-C2, 
C3-C4 structural isoforms, respectively, were observed when t-TM EGF D4 




Figure 3.3   Analysis of t-TM EGF D4 air oxidation products by reversed-phase chromatography. 
Retention volume of the three monomeric structural isoforms obtained were compared with that of 
regioselectively-synthesized structural isoforms. 
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Figure 3.4   Analysis of t-TM EGF D4 redox reagent-mediated oxidation products by reversed-
phase chromatography. Retention volume of the three monomeric structural isoforms obtained were 
compared with that of regioselectively-synthesized structural isoforms. Abbreviations: GSH ! Reduced 
glutathione; GSSG ! Oxidized glutathione.   
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Table 3.3   Percentages of structural isoforms obtained from oxidative folding of t-TM EGF D4 and t-TM EGF D5 in 
various conditions 
(A) Oxidative folding of t-TM EGF D4 
 (---)a, b +6 M Gn.HClc +0.5 M NaCld 










C1-C3, C2-C4 (Native) 67.53 ± 0.69 69.08 ± 0.57 18.48 ± 1.15 31.31 ± 0.98 74.66 ± 0.87 
C1-C2, C3-C4 21.13 ± 0.67 18.96 ± 0.57 52.72 ± 0.94 47.28 ± 0.32 17.18 ± 0.45 
C1-C4, C2-C3 11.34 ± 0.63 11.96 ± 0.27 28.80 ± 0.82 21.42 ± 0.71 8.17 ± 0.49 
 
 
(B) Oxidative folding of t-TM EGF D5 
 (---)a, b +6 M Gn.HClc +0.5 M NaCld 










C1-C3, C2-C4  20.57 ± 0.34 20.36 ± 0.11 17.69 ± 0.35 19.11 ± 0.15 23.32 ± 0.43 
C1-C2, C3-C4 (Native) 60.40 ± 0.64 60.67 ± 1.07 61.80 ± 0.91 61.46 ± 0.77 54.40 ± 1.78 
C1-C4, C2-C3 19.03 ± 0.30 18.97 ± 0.98 20.52 ± 0.67 19.43 ± 0.63 22.28 ± 1.98 
a Discussion in Section 3.2, b Normal oxidative folding conditions (without denaturant or salt) 
c Discussion in Section 3.3 




Figure 3.5! ! !Pairwise comparison of t-TM EGF D4 structural isoform proportions obtained from 
air oxidation and redox reagent-mediated oxidation studies. Student!s t-test (independent samples) 
using arcsine transformed-values were used for the calculation of probability (p)-values. Difference in 
proportion between corresponding structural isoforms is deemed to be significant when the p-value is 
less than 0.05 (one-tailed).  
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3.2.2   In vitro oxidative folding of t-TM EGF D5 
Oxidative folding of reduced t-TM EGF D5 was performed using air oxidation 
and redox reagent-mediated folding: 
(a)  Air oxidation-mediated folding of reduced t-TM EGF D5 was completed in 
approximately 72 hrs as judged by the Ellman!s test. Structural isoforms 
obtained from the reaction were resolved by reversed-phase 
chromatography and as expected, three monomeric isoforms were 
obtained (Figure 3.6).  
(b)  Folding of t-TM EGF D5 in redox buffer system was performed over 48 
hrs. Like air oxidation, three monomeric isoforms were obtained (Figure 
3.7).  
Like t-TM EGF D4, the retention volume of t-TM EGF D5 structural isoforms 
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Figure 3.6   Analysis of t-TM EGF D5 air oxidation products by reversed-phase chromatography. 
Retention volume of the three monomeric structural isoforms obtained were compared with that of 




Figure 3.7   Analysis of t-TM EGF D5 redox reagent-mediated oxidation products by reversed-
phase chromatography. Retention volume of the three monomeric structural isoforms obtained were 
compared with that of regioselectively-synthesized structural isoforms. Abbreviations: GSH ! Reduced 
glutathione; GSSG ! Oxidized glutathione. 
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obtained from both oxidative folding studies matched well with that of 
regioselectively-synthesized structural isoforms. Thus, peak identities were 
assigned and the relative proportions of the three isoforms were calculated 
based on the area of the respective peaks (Table 3.3B: Purple columns). 
Unlike the folding tendency of t-TM EGF D4, results from these oxidative 
folding experiments showed that t-TM EGF D5 has a folding preference 
towards the C1-C2, C3-C4 isoform instead of the C1-C3, C2-C4 isoform. 
However, it should be noted that C1-C2, C3-C4 is the native disulfide-
connectivity of t-TM EGF D5. Thus, in a way similar to t-TM EGF D4, t-TM 
EGF D5 has a folding preference towards its native isoform.  
With regards to the difference in proportions of corresponding structural 
isoforms obtained from air oxidation and redox reagent-mediated oxidation 
studies, the Student!s t-test (with arcsine transformed values) revealed no 
significant difference (at 0.05 level of significance) in all structural isoforms 
between the two studies (Figure 3.8 and AP Table A3.2). 
 
3.2.3   Truncated TM EGF D4 and TM EGF D5 preferentially 
fold into their respective native isoform 
Similar to air oxidation-mediated folding, the highest yield obtained from redox 
reagent-mediated folding was the respective native isoforms of both domains. 
This is approximately 70% for t-TM EGF D4 (C1-C3, C2-C4) and 60% for t-TM 
EGF D5 (C1-C2, C3-C4). From these redox-based experiments, it is reasonable 
to conclude that the respective native isoforms of both domains are the most 
thermodynamically stable among the three possible structural isoforms.  
! "#!
!
Figure 3.8   Pairwise comparison of t-TM EGF D5 structural isoform proportions obtained from 
air oxidation and redox reagent-mediated oxidation studies. Student!s t-test (independent samples) 
using arcsine transformed-values were used for the calculation of probability (p)-values. Difference in 
proportion between corresponding structural isoforms is deemed to be significant when the p-value is 
less than 0.05 (one-tailed).  
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Together, these results demonstrated that fully reduced t-TM EGF D4 and t-
TM EGF D5 still preferentially fold into their native, most thermodynamically 
stable, structural isoform even when the C-terminal segment of both EGF-like 
domains (encompassing C5 and C6) were absent. This prominent folding 
tendency suggests the existence of structural determinants that lies within the 
N-terminal segment (encompassing C1 to C4) of both domains and that their 
respective C-terminal segments do not play a major role in dictating the 
disulfide-connectivity of the first two disulfide bonds. Logically, the respective 
structural determinants of both domains must be of different or opposing 
properties so as to dictate the canonical versus non-canonical EGF-like 
domain fold of TM EGF D4 and TM EGF D5, respectively. 
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3.3     Contribution of Side-chain Interactions in the 
Folding Tendencies of t-TM EGF D4 and t-TM 
EGF D5 
To identify the structural determinants which are located in the N-terminal 
segment of the EGF-like domain, it is important to identify the dominant forces 
that drives and stabilizes the fold of t-TM EGF D4 and t-TM EGF D5. To this 
end, it is of interest to detect any difference in the folding tendency of both 
truncated EGF-like domains upon manipulation of the oxidative folding 
environment. This would tell us the relative contribution of specific side-chain 
interactions in stabilizing the native fold of the domain and thus aid in the 
identification of the dominant force. Any knowledge of the dominant force 
would then indicate the physical-chemical properties of the amino acid 
residues involved in the folding code of the EGF-like domain. 
To determine the role of side-chain interactions in dictating the folding 
tendency of t-TM EGF D4 and t-TM EGF D5, 6 M Gn.HCl was included in the 
oxidative folding buffer to disrupt side-chain interactions in the peptide. The 
extent of change in the folding tendency of both domains would be compared 
to ascertain if differences in the necessity of side-chain interactions is the 
main contributor to the two EGF-like domains! different folding tendency. 
 
3.3.1   In vitro oxidative folding of t-TM EGF D4 in the 
presence of 6 M Gn.HCl  
Air oxidation and redox reagent-mediated folding of t-TM EGF D4 was 
performed with the inclusion of 6 M Gn.HCl in the folding buffer: 
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(a)  For air oxidation in the presence of 6 M Gn.HCl, the reaction was 
completed in approximately 72 hrs as judged by the Ellman!s test. 
Analysis by reversed-phase chromatography revealed that all three 
monomeric isoforms were obtained (Figure 3.9). 
(b)  The redox reagent-mediated oxidative folding of t-TM EGF D4 in the 
presence of 6 M Gn.HCl was allowed to proceed for 48 hours. It also 
yielded three monomeric isoforms which were resolved by reversed-
phase chromatography (Figure 3.10).  
Peak identities were assigned and their respective peak area revealed that 
the highest yield obtained from both oxidative folding studies was the C1-C2, 
C3-C4 isoform (Table 3.3A: Green columns). This meant that t-TM EGF D4 
has a folding preference towards the C1-C2, C3-C4 isoform, instead of its 
native C1-C3, C2-C4 isoform, when folded in the presence of denaturant (Note: 
more detailed discussion in Section 3.3.3). 
Pairwise comparison of corresponding structural isoforms from both oxidative 
folding studies was performed. The Student!s t-test (with arcsine transformed-
percentage values) showed significant difference in the proportions of all 
structural isoforms obtained ! i.e. When folding was performed via the redox 
buffer system in the presence of denaturant, the proportion of the C1-C3, C2-
C4 (native) isoform obtained was much higher. This resulted in the 
concomitant decrease in the proportions of the C1-C2, C3-C4 and C1-C4, C2-C3 
isoforms (Figure 3.11 and AP Table A3.3). The increase in the C1-C3, C2-C4 
(native) isoform in redox buffer system could be attributed to the redox 
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Figure 3.9   Analysis of t-TM EGF D4 products obtained from air oxidation in the presence of 6 M 
Gn.HCl by reversed-phase chromatography. Retention volume of the three monomeric structural 




Figure 3.10   Analysis of t-TM EGF D4 products obtained from redox reagent-mediated oxidation 
in the presence of 6 M Gn.HCl by reversed-phase chromatography. Retention volume of the three 
monomeric structural isoforms obtained were compared with that of regioselectively-synthesized 
structural isoforms. Abbreviations: GSH ! Reduced glutathione; GSSG ! Oxidized glutathione. 
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reagent-mediated increase in the most thermodynamically stable isoform of t-
TM EGF D4 (i.e. C1-C3, C2-C4). Here, redox reagent-mediated oxidation had 
increase the proportion of C1-C3, C2-C4 isoform despite an overwhelming 
tendency for t-TM EGF D4 to fold into the C1-C2, C3-C4 isoform in the 
presence of 6 M Gn.HCl. 
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Figure 3.11   Pairwise comparison of t-TM EGF D4 structural isoform proportions obtained from 
air oxidation (with 6 M Gn.HCl) and redox reagent-mediated oxidation (with 6 M Gn.HCl) studies. 
Student!s t-test (independent samples) using arcsine transformed-values were used for the calculation 
of probability (p)-values. Difference in proportion between corresponding structural isoforms is deemed 
to be significant when the p-value is less than 0.05 (one-tailed).  
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3.3.2   In vitro oxidative folding of t-TM EGF D5 in the 
presence of 6 M Gn.HCl 
Air oxidation and redox reagent-mediated folding of t-TM EGF D5 was 
performed with the inclusion of 6 M Gn.HCl in the folding buffer: 
(a) In the presence of denaturant, air oxidation-mediated folding was 
completed in approximately 48 hrs as judged by the Ellman!s test. 
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Subsequent analysis by reversed-phase chromatography showed that 
three structural isoforms were obtained (Figure 3.12). 
(b)  The folding of t-TM EGF D5 using redox reagent-mediated oxidation in the 
presence of denaturant also yielded three structural isoforms (Figure 
3.13). 
Quantification of structural isoform proportions based on relative peak areas 
revealed that the folding tendency of t-TM EGF D5 was not affected by the 
presence of 6 M Gn.HCl in the oxidative folding buffers. t-TM EGF D5 still 
showed a folding preference towards its native (C1-C2, C3-C4) isoform (Table 
3.3B: Green columns). This is in contrast to t-TM EGF D4 whose folding 
tendency was altered when denaturant was added to the oxidative folding 
buffers (Note: more detailed discussion in Section 3.3.3).  
Pairwise comparison of corresponding structural isoforms from both set of 
experiments using Student!s t-test (with arcsine transformed values) revealed 
no difference in proportions, except for a slightly larger percentage of C1-C3, 
C2-C4 isoform in the redox reagent mediated-experiments (Figure 3.14 and AP 
Table A3.4). 
 
3.3.3   Side-chain interaction is necessary for the canonical 
C1-C3, C2-C4 fold of the EGF-like domain 
Disruption of side-chain interactions using 6 M Gn.HCl in the oxidative folding 
buffer had a different effect on the folding tendencies of t-TM EGF D4 and t-




Figure 3.12   Analysis of t-TM EGF D5 products obtained from air oxidation in the presence of 6 
M Gn.HCl by reversed-phase chromatography. Retention volume of the three monomeric structural 





Figure 3.13   Analysis of t-TM EGF D5 products obtained from redox reagent-mediated oxidation 
in the presence of 6 M Gn.HCl by reversed-phase chromatography. Retention volume of the three 
monomeric structural isoforms obtained were compared with that of regioselectively-synthesized 





Figure 3.14!!!Pairwise comparison of t-TM EGF D5 structural isoform proportions obtained from 
air oxidation (with 6 M Gn.HCl) and redox reagent-mediated oxidation (with 6 M Gn.HCl) studies. 
Student!s t-test (independent samples) using arcsine transformed-values were used for the calculation 
of probability (p)-values. Difference in proportion between corresponding structural isoforms is deemed 
to be significant when the p-value is less than 0.05 (one-tailed). 
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3.3.3.1  Disruption of side-chain interactions led to change in folding 
tendency of t-TM EGF D4 
For t-TM EGF D4, the loss of side-chain interactions resulted in the change of 
folding tendency from that of C1-C3, C2-C4 (native) to C1-C2, C3-C4. This shift 
in folding tendency was rather prominent as the percentage of native isoform 
dropped from 67.53 ± 0.69% to 18.48 ± 1.15% when 6 M Gn.HCl was 
included in the air oxidation buffer, and from 69.08 ± 0.57% to 31.31 ± 0.97% 
when the denaturant was included in redox buffer. To put these numbers into 
perspective, the decreased native isoform proportion corresponds to only 0.26 
(about one quarter) and 0.45 (about half) of the original air oxidation and 
redox reagent-mediated oxidation proportion, respectively.  
For the C1-C2, C3-C4 isoform, the disruption of side-chain interactions in the 
folding peptide had benefited its numbers. When 6 M Gn.HCl was included in 
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the air oxidation buffer, the percentage of C1-C2, C3-C4 isoform increased from 
21.13 ± 0.67% to 52.72 ±0.94%. For the inclusion of denaturant into the redox 
buffer, the percentage of C1-C2, C3-C4 isoform increased from 18.96 ± 0.57% 
to 47.28 ± 0.31%. In both cases, the increased C1-C2, C3-C4 proportion 
corresponds to 2.5 times the original amount obtained from air oxidation and 
redox reagent-mediated oxidation.  
To lend further support to the observation that the folding tendency of t-TM 
EGF D4 was affected when side-chain interactions were disrupted, the 
Student!s t-test (with arcsine transformed values) was performed. Pairwise 
comparison of corresponding structural isoform proportions showed 
statistically significant decrease and increase in the proportions of C1-C3, C2-
C4 and C1-C2, C3-C4 isoforms, respectively, when oxidative folding was 
conducted in the presence of denaturant (Figure 3.15 and Figure 3.16, AP 
Table A3.5 and AP Table A3.6).  
Thus, the folding of t-TM EGF D4 into its native isoform is highly dependent 
upon the presence of side-chain interactions. In its absence, the t-TM EGF D4 
opted for the fold with the C1-C2, C3-C4 disulfide-connectivity which is 
interestingly the native conformer of t-TM EGF D5, the non-canonical EGF-
like domain.  
 
3.3.3.2  Disruption of side-chain interactions did not affect the folding   
tendency of t-TM EGF D5 
Based on the results presented in Section 3.3.2, it is now apparent that the 
folding tendency of t-TM EGF D5 was not affected by the disruption of side-
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Figure 3.15! ! !Pairwise comparison of t-TM EGF D4 structural isoform proportions obtained from 
air oxidation and air oxidation (with 6 M Gn.HCl) studies. Student!s t-test (independent samples) 
using arcsine transformed-values were used for the calculation of probability (p)-values. Difference in 
proportion between corresponding structural isoforms is deemed to be significant when the p-value is 





Figure 3.16! ! !Pairwise comparison of t-TM EGF D4 structural isoform proportions obtained from 
redox reagent-mediated oxidation and redox reagent-mediated oxidation (with 6 M Gn.HCl) 
studies. Student!s t-test (independent samples) using arcsine transformed-values were used for the 
calculation of probability (p)-values. Difference in proportion between corresponding structural isoforms 
is deemed to be significant when the p-value is less than 0.05 (one-tailed).  
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chain interactions. When looking at the exact numbers, the presence of 6 M 
Gn.HCl in both oxidative folding buffer had resulted in a slight but statistically 
significant decrease in the C1-C3, C2-C4 isoform, without affecting the 
proportion of the C1-C2, C3-C4 (native) isoform at all (Figure 3.17 and Figure 
3.18, AP Table A3.7 and Table A3.8).  
In conclusion, the results obtained from oxidative folding studies on t-TM EGF 
D4 and t-TM EGF D5 in the presence of 6 M Gn.HCl suggested that the 
absence of side-chain interactions generally decreases the C1-C3, C2-C4 
isoform and increases the C1-C2, C3-C4 isoform regardless of the exact 
identities of the EGF-like domains (i.e. whether it is t-TM EGF D4 or t-TM EGF 
D5). In view of this generalized effect, the finding that the absence of side-
chain interactions disfavors the C1-C3, C2-C4 conformer could be applicable to 
other canonical EGF-like domains as well.  
 
!
Figure 3.17! ! !Pairwise comparison of t-TM EGF D5 structural isoform proportions obtained from 
air oxidation and air oxidation (with 6 M Gn.HCl) studies. Student!s t-test (independent samples) 
using arcsine transformed-values were used for the calculation of probability (p)-values. Difference in 
proportion between corresponding structural isoforms is deemed to be significant when the p-value is 
less than 0.05 (one-tailed).  
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Figure 3.18! ! !Pairwise comparison of t-TM EGF D5 structural isoform proportions obtained from 
redox reagent-mediated oxidation and redox reagent-mediated oxidation (with 6 M Gn.HCl) 
studies. Student!s t-test (independent samples) using arcsine transformed-values were used for the 
calculation of probability (p)-values. Difference in proportion between corresponding structural isoforms 
is deemed to be significant when the p-value is less than 0.05 (one-tailed).  
 
3.3.3.3  Putting the requirement for side-chain interactions into the 
context of nature!s selection for t-TM EGF D4!s and t-TM EGF 
D5!s structural determinants 
From the above discussion, it is clear that the EGF-like domain requires side-
chain interactions to acquire its canonical fold with the C1-C3, C2-C4 disulfide-
connectivity. As such, the structural determinants of t-TM EGF D4 was 
probably “chosen” to enable optimal participation in side-chain interactions so 
that the domain could preferentially fold into it C1-C3, C2-C4 isoform under 
normal oxidative conditions. When these structural determinants were 
prevented from interacting, the domain would not be able to fold into its native 
isoform and instead adopt an alternate isoform which does not require side-
chain interactions to form. 
On the other hand, since the folding of the C1-C2, C3-C4 isoform does not 
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require “information” from side-chain interactions, it is plausible to assume 
that t-TM EGF D5!s structural determinants, unlike that of t-TM EGF D4, are 
“selected” for optimal disengagement in side-chain interactions under normal 
oxidative conditions. Therefore, the preferential folding of t-TM EGF D5 into its 
native isoform would not be affected even when 6 M Gn.HCl was included in 
the oxidative folding buffer. In such a case, any side-chain interactions that 
occur in t-TM EGF D5 would not be the main determinant of its native fold and 
the associated disulfide-connectivity.  
With regards to the C1-C4, C2-C3 isoform, the proportion of this particular 
isoform in t-TM EGF D4 had also been shown to increase significantly when 
oxidative folding was performed in the presence of denaturant. However, it did 
not manage to reach a proportion as high as that of the C1-C2, C3-C4 isoform. 
This is probably because of the shorter inter-cysteine loop between C2 and C3 
which disfavors formation of a disulfide bond between these two cysteine 
residues due to steric hindrance/clashes. Thus, it remains to be seen whether 
a longer inter-cysteine loop would draw folding tendencies away from the C1-
C3, C2-C4 and C1-C2, C3-C4 isoform. For this purpose, an EGF-like domain 
with a longer inter-cysteine loop between C2 and C3 would be needed for 
verification. An example of this would be EGF-like domain 2 of human 
thrombospondin-2 which has eight residues between C2 and C3 instead of just 
three in TM EGF D4 and TM EGF D5. Moreover, the short C2-C3 inter-
cysteine loop of TM EGF D4 and D5 might be “nature!s strategy” to divert 
folding away from the C1-C4, C2-C3 isoform so that only binary decision 
between C1-C3, C2-C4 or C1-C2, C3-C4 is needed. This binary decision then 
! "#!
depends on whether their respective structural determinants participate in 
side-chain interactions or not.  
 
3.3.3.4  Probing into the nature of the side-chain interaction  
Although side-chain interactions had been demonstrated to be necessary for 
the EGF-like domain to fold into its canonical C1-C3, C2-C4 fold, the nature of 
the side-chain interactions remained elusive. This is because the effects of 
Gn.HCl on side-chain interactions could not be differentiated between 
hydrophobic interaction or electrostatic interaction ! i.e. The guanidinium ion 
could interact with hydrophobic side-chains to disrupt hydrophobic interactions 
[85, 86], and in addition, the ionic nature of Gn.HCl (i.e. guanidinium cation 
and chloride anion) could also mask any electrostatic interactions/repulsions 
present in the protein molecule [87].  
Consideration for hydrophobic side-chain interactions as the force responsible 
for dictating the C1-C3, C2-C4 fold was based on the fact that compact protein 
structure is often stabilized by hydrophobic interactions [88]. Based on the 
solution structure of TM EGF D4-D5 solved by Wood, Sampoli Benitez and 
Komives [PDB: 1DQB] [79], it was observed that the t-TM EGF D4 segment 
folds into a rather compact structure (Figure 3.19A). Thus, hydrophobic 
interaction is likely to be involved in guiding the fold of the domain, as well as, 
dictating the C1-C3, C2-C4 disulfide-connectivity that reinforces the compact 
structure. On the other hand, the t-TM EGF D5 segment of the TM EGF D4-
D5 structure folds into a less compact structure (Figure 3.19B) with most its 




Figure 3.19   Space-filled model of (A) t-TM EGF D4 and (B) t-TM EGF D5. The model of these 
segments were extracted from PDB: 1DQB, which represents the solution structure of the TM EGF D4-




side-chain interaction as the dominant force in guiding the fold of the C1-C2, 
C3-C4 structural isoform. 
The next consideration is that of electrostatic interactions. Although 
electrostatic interaction was also disrupted by high concentration of Gn.HCl, it 
was not likely the cause of t-TM EGF D4!s failure to follow its native folding 
tendency in the presence of denaturant. This is because oppositely-charged 
residues in t-TM EGF D4 are all located in the N-terminal half of the truncated 
domain (Figure 3.1A), and are thus unlikely to be involved in guiding the 
formation of the overall compact structure under normal oxidative conditions.  
As for the acidic t-TM EGF D5, it only contain three charged residues ! i.e. 
one aspartic acid located on each side of C3 and one glutamic acid N-terminal 
to C4 (Figure 3.1B). These common charges might result in electrostatic 
repulsion that could bring C3 and C4 further away from each other than the 
equivalent cysteine residues in t-TM EGF D4. Indeed, a simple measurement 
of the C"-C" distance of C3 and C4 in t-TM EGF D4 and t-TM EGF D5 yield a 
distance of 4.828 Å and 5.400 Å, respectively. Structurally, disulfide bond 
formation between cysteine residues that are too close together (e.g. such as 
across two strands in a #-sheet [89]) creates strain and is thus unfavorable. 
Thus, the increased distance between C3 and C4 in t-TM EGF D5 might be 
more favorable for disulfide bond formation between these two residues to 
create the C1-C2, C3-C4 isoform. However, the 6 M Gn.HCl-experiments could 
disprove the above argument. The high content of guanidinium cation could 
possibly shield the negatively charged acidic residues in t-TM EGF D5 to 
reduce the effect of electrostatic repulsion. If electrostatic repulsion (and thus 
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lack of side-chain interactions) is responsible for the favorable formation of the 
C3-C4 disulfide bond, the proportion of the C1-C2, C3-C4 isoform would be 
brought down by the presence of Gn.HCl in the oxidative folding buffer. 
However, this did not happen and the C1-C2, C3-C4 remained the dominant 
isoform, with percentage values unaltered, in oxidative folding experiments 
conducted in the presence of 6 M Gn.HCl. 
In view of these considerations, it seemed that hydrophobic side-chain 
interactions and lack thereof is responsible for the differential folding 
tendencies of t-TM EGF D4 and t-TM EGF D5, respectively. Thus, to confirm 
this conclusion, another set of experiments, using a different chemical reagent 
to manipulate the oxidative folding environment, was performed. Here, 0.5 M 
NaCl was chosen as the reagent ! i.e. NaCl like Gn.HCl could disrupt 
electrostatic interactions [90], but unlike Gn.HCl which disrupts hydrophobic 
interactions, the presence of high NaCl concentration increases the 
hydrophobic effect in proteins (a phenomena that serves as a basis for 
hydrophobic interaction chromatography) [91]. Here, it was hypothesized that 
the inclusion of 0.5 M NaCl to the folding buffer would result in the increase of 
the C1-C3, C2-C4 structural isoform in both t-TM EGF D4 and t-TM EGF D5 as 
the presence of hydrophobic interactions favor the formation of this structural 
isoform. 
! "#!
3.4     Contribution of Hydrophobic Interactions in the 
Folding Tendencies of t-TM EGF D4 and t-TM 
EGF D5 
To determine the role of hydrophobic interactions in dictating the folding 
tendency of t-TM EGF D4 and t-TM EGF D5, 0.5 M NaCl was included in the 
redox oxidative folding buffer to increase the hydrophobic effect, and to 
disrupt/mask any possible electrostatic interactions and repulsions. Alteration 
in the folding tendency of both domains was then noted to ascertain if 
hydrophobic interactions is the main contributor to the C1-C3, C2-C4 fold of the 
canonical EGF-like domain. 
 
3.4.1  In vitro oxidative folding of t-TM EGF D4 in the presence 
of 0.5 M NaCl 
Folding of t-TM EGF D4 in the presence of 0.5 M NaCl was performed using 
the redox buffer system and three monomeric isoforms were obtained (Figure 
3.20A). Based on the relative yield of the respective structural isoforms (Table 
3.3A: Orange columns), the result showed that t-TM EGF D4 still had a 
preference towards its native isoform when folded in the presence of high salt 
content.   
 
3.4.2  In vitro oxidative folding of t-TM EGF D5 in the presence 
of 0.5 M NaCl 
In the presence of 0.5 M NaCl, redox reagent-mediated folding of t-TM EGF 
D5 yielded three monomeric isoforms (Figure 3.20B). Like t-TM EGF D4, t-TM 
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EGF D5 still showed a folding preference towards its native isoform when 
folded in the presence of 0.5 M NaCl (Table 3.3B: Orange columns). 
 
!
Figure 3.20! ! ! Analysis of (A) t-TM EGF D4 and (B) t-TM EGF D5 products obtained from redox 
reagent-mediated oxidation in the presence of 0.5 M NaCl by reversed-phase chromatography. 
Retention volume of the monomeric structural isoforms obtained were compared with that of 
regioselectively-synthesized structural isoforms for identification. 
 
3.4.3  Hydrophobic interaction is necessary for the canonical 
C1-C3, C2-C4 fold of the EGF-like domain 
As high salt content is known to disrupt electrostatic attraction, the preferential 
folding of t-TM EGF D4 into its native C1-C3, C2-C4 isoform even in the 
presence of 0.5 M NaCl showed that electrostatic interaction is not the nature 
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of the side-chain interaction involved in dictating the C1-C3, C2-C4 fold. 
Student!s t-test comparison of corresponding t-TM EGF D4 structural isoforms 
obtained from oxidative folding in the absence versus presence of 0.5 M NaCl 
(Figure 3.21 and AP Table A3.9) showed a significant increase in the 
proportion of the native C1-C3, C2-C4 isoform in the experiments performed 
with NaCl. This was accompanied by significant decrease in the proportion of 
non-native structural isoforms (C1-C2, C3-C4 and C1-C4, C2-C3). Based on 
these results, increased in proportion of the C1-C3, C2-C4 isoform was deemed 
to be attributed to increased hydrophobic effect caused by the presence of 0.5 
M NaCl. This reinforces the conclusion from Section 3.3.3.4 that the identity of 
the side-chain interactions involved in dictating the C1-C3, C2-C4 fold is that of 
hydrophobic interactions. 
As for t-TM EGF D5, although it still folds predominantly into its native C1-C2, 
C3-C4 isoform in NaCl-containing folding buffer, pairwise comparison of 
corresponding structural isoforms obtained from oxidative folding in the 
absence versus presence of 0.5 M NaCl (Figure 3.22 and AP Table A3.10) 
showed a significant decrease in the proportion of its native C1-C2, C3-C4 
isoform in experiments performed with NaCl. This decrease was accompanied 
by an increase in the canonical EGF-like C1-C3, C2-C4 isoform. This was 
probably due to salt-induced increase in hydrophobic effect which in turn 
make the folding into the C1-C3, C2-C4 conformer more favorable regardless of 
the exact identities of the EGF-like domains. In addition, as high salt content 
also mask electrostatic repulsion, the increased folding of t-TM EGF D5 into 
the compact C1-C3, C2-C4 isoform could also be attributed to this effect. 
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Figure 3.21! ! !Pairwise comparison of t-TM EGF D4 structural isoform proportions obtained from 
redox reagent-mediated oxidation and redox reagent-mediated oxidation (with 0.5 M NaCl) 
studies. Student!s t-test (independent samples) using arcsine transformed-values were used for the 
calculation of probability (p)-values. Difference in proportion between corresponding structural isoforms 





Figure 3.22! ! !Pairwise comparison of t-TM EGF D5 structural isoform proportions obtained from 
redox reagent-mediated oxidation and redox reagent-mediated oxidation (with 0.5 M NaCl) 
studies. Student!s t-test (independent samples) using arcsine transformed-values were used for the 
calculation of probability (p)-values. Difference in proportion between corresponding structural isoforms 
is deemed to be significant when the p-value is less than 0.05 (one-tailed).  
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However, in view of! the! observations made from the Gn.HCl-containing 
experiments, this is probably not the case. 
To conclude, hydrophobic interactions had been identified as the dominant 
force that drives the C1-C3, C2-C4 fold of the canonical EGF-like domains. 
Revisiting what had been mentioned in Section 3.3.3.3, this meant that the 
structural determinants of the canonical EGF-like domain is “designed” to 
optimally engage specifically in hydrophobic interaction. On the contrary, the 
structural determinants of the C1-C2, C3-C4 isoform, are probably more polar 
(or less hydrophobic) and thus prefer to interact with the aqueous medium. 
Although polar side-chain interactions can also occur, the amino acid 
sequence of t-TM EGF D5 is probably “designed” such that balance of 
physical-chemical forces in the folding peptide could not outcompete the 
aqueous solvent for interaction with the side-chain of the structural 
determinants.  
The identification of the dominant force that dictates the C1-C3, C2-C4 fold 
provided clues to the identity of the structural determinants in t-TM EGF D4. 
Thus, it is now of interest to identify the key hydrophobic residues in t-TM EGF 
D4 that is involved in dictating its canonical EGF-like fold. 
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3.5     Identification of Key Hydrophobic Residues as 
Structural Determinants of the Canonical EGF-
like Domain fold in t-TM EGF D4 
Based on the experimental evidence provided in Section 3.4, it can be 
suggested that the increase in hydrophobic interactions/effect generally 
increase folding into the C1-C3, C2-C4 isoform regardless of the exact identities 
of the EGF-like domains involved. In view of this generalized effect, the finding 
that hydrophobic interaction is the nature of the side-chain interactions that 
guides folding towards the C1-C3, C2-C4 fold could be applicable to other 
canonical EGF-like domains as well.  
Therefore, for amino acids to satisfy the role of structural determinants in the 
canonical EGF-like domain, they have to be hydrophobic in nature. However, 
an addition requirement is that the amino acid residues at their equivalent 
positions in the non-canonical fold have to be either hydrophilic or less 
hydrophobic. This additional requirement assumes that the structural 
determinants for the C1-C2, C3-C4 fold are located in the same position along 
the amino acid sequence as that of the C1-C3, C2-C4 fold. This assumption is 
based on the following reasoning: 
The EGF-like domain is an evolutionarily conserved modular unit with diverse 
functionality. Therefore, the positions of its structural determinants have to be 
conserved, while accommodating varied “functional” residues between them, 
to maintain the overall canonical fold across the domain family. Thus, the 
switch from canonical to non-canonical EGF-like domain fold in TM EGF D5 is 
more likely to be caused by a switch in chemical properties of the structural 
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determinants which are located at conserved position, rather than the 
“relocation” of structural determinants to cause a different fold. In the case of 
TM EGF D5, the C1-C2, C3-C4 fold is determined to be the result of the 
absence of side-chain interactions between key structural determinants.  
To identify potential hydrophobic residues in t-TM EGF D4 for further studies, 
sequence alignment of t-TM EGF D4 and other canonical EGF-like domains 
from various proteins was performed to identify conserved hydrophobic 
residues. These other canonical EGF-like domains were chosen on the basis 
that their three-dimensional structures had been solved. Thus, EGF-like 
domains whose three-dimensional structures are unknown, but are assumed 
to possess the C1-C3, C2-C4 disulfide connectivity based on sequence 
homology, were not chosen.  
Interestingly, results from the sequence alignment showed only one 
conserved hydrophobic/aromatic residue which is located two residues N-
terminal to the C4 residue (Figure 3.23). This hydrophobic/aromatic residue is 
also present in TM EGF D4 of other organisms, but is absent from TM EGF 
D5 (Figure 3.24). The amino acid in the equivalent position in TM EGF D5 is 
substituted by less hydrophobic residues. Although it seemed unlikely that a 
single residue is all that is needed to guide the folding of the EGF-like domain 
towards the C1-C3, C2-C4 conformer, this possibility could not be ruled out ! 
Research on the structural determinants of "-conotoxin ImI showed that a 
mere switch from amide to acid at its C-terminal is enough to switch its 
disulfide-connectivity preference from C1-C3, C2-C4 to C1-C4, C2-C3 [41]. 
Here, the identified hydrophobic/aromatic residue satisfies the two criteria for 
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Figure 3.23   Sequence alignment of canonical EGF-like domains from various proteins. Shown 
here are the sequences of the EGF-like domain segment encompassing C1 to C4. The conserved 
hydrophobic/aromatic residue is highlighted in green. Conserved cysteine residues of the EGF-like 
domain are highlighted in yellow.  
!
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Figure 3.24   Sequence alignment of t-TM EGF D4 and t-TM EGF D5 from various organisms. The 
conserved hydrophobic/aromatic residue in t-TM EGF D4 is highlighted in green. The less hydrophobic 
residues at the equivalent position in t-TM EGF D5 is highlighted in pink. The conserved cysteine 
residues of the EGF-like domain are highlighted in yellow. 
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being a structural determinant in the canonical fold of the EGF-like domain. To 
further verify its suitability as a structural determinant, the structures of these 
canonical EGF-like domains were inspected to see if this conserved residue is 
in hydrophobic contact with other residues in the domain. The analysis 
revealed that this conserved residue mainly makes hydrophobic contact with 
amino acid residues located within the first inter-cysteine loop (Figure 3.25). 
Examples of this contact within the canonical EGF-like domain is depicted in 
Figure 3.26 with EGF-like domain 1 of human coagulation factor VII (Figure 
3.26A) and the EGF-like domain of human Pro-neuregulin-1 (Figure 3.26B).  
When looking specifically at TM EGF D4 and D5, the conserved 
hydrophobic/aromatic residue of Tyr25 in TM EGF D4 is in close contact with 
Ala11 of the first inter-cysteine loop (Figure 3.27A). On the contrary, the 
amino acids residues at their equivalent positions (Figure 3.27B) in TM EGF 
D5 (Thr50 and Ala62) were not in contact (Figure 3.27C). 
Although the contact between the conserved hydrophobic/aromatic residues 
and the identified residues in the first inter-cysteine loops might not represent 
hydrophobic contacts during the transition state of folding, these contacts are 
needed for the compact C1-C3, C2-C4 fold since they bring the third inter-
cysteine loop (near the C-terminal) in close proximity to the first inter-cystine 
loop (near the N-terminal). Thus, any disruption of these contacts would 
probably destabilize the C1-C3, C2-C4 structure to create the more loosely 
packed isoform with the C1-C2, C3-C4 disulfide-connectivity. 
To experimentally verify the conserved hydrophobic/aromatic residue as the 






Figure 3.25   Identification of residues that interacts with the conserved hydrophobic/aromatic 
residues in various canonical EGF-like domains. Shown here are the sequences of the EGF-like 
domain segment encompassing C1 to C4. By inspection of the three-dimensional structure of the various 
EGF-like domains, amino acid residues which are in contact with the conserved/hydrophobic residue are 
identified. Here, the interacting residues are indicated in bold font. The conserved hydrophobic/aromatic 
residue is highlighted in green. The conserved cysteine residues of the EGF-like domain are highlighted 
in yellow.  
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Figure 3.26   Residues interacting with the conserved hydrophobic/aromatic residues in (A) 
coagulation factor VII EGF-like domain 1 and (B) Pro-neuregulin-1 EGF-like domain. Depicted 
here are the EGF-like domain segments encompassing C1 to C4. The model of these segments were 
extracted from PDB: 1FF7 and PDB: 1HAE, respectively. Interacting residues were labeled, and the 
indicated positions are in accordance to the position numbers used in their respective PDB files. 
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Figure 3.27   Residues interacting with the conserved hydrophobic/aromatic residue in the 
canonical EGF-like t-TM EGF D4. (A) Model of t-TM EGF D4 showing interaction between the 
conserved hydrophobic/aromatic residue of Y25 interacting with A11 of the first inter-cysteine loop. (B) 
Identification of the equivalent residues in t-TM EGF D5 which are indicated in (red) bold font. (C) Model 
of t-TM EGF D5 showing non-interaction between T50 and A62. The models of these segments were 
extracted from PDB: 1DQB. Positions of residues are labeled in accordance to the position numbers 
used in the PDB files. 
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domain, modified t-TM EGF D4 with Tyr25 substituted with threonine was 
synthesized. The threonine residue is more hydrophilic than the tyrosine 
residue as it lacks the hydrophobic aromatic ring of tyrosine. Moreover, it was 
chosen as a substitution for tyrosine as it also carries a hydroxyl group, thus 
making the hydrophilic substitution based solely on the removal of the 
hydrophobic aromatic ring.  
The fully reduced modified t-TM EGF D4 peptide was then folded using air 
oxidation or redox reagent-mediated oxidation, either in the absence or 
presence of 6 M Gn.HCl. The dominant structural isoform obtained from these 
folding studies were then identified based on elution profile comparison with 
that of regioselectively-synthesized structural isoforms. If the conserved 
hydrophobic/aromatic residue is the structural determinant of the C1-C3, C2-C4 
fold, the proportion of this conformer should decrease significantly in t-TM 
EGF D4 after its substitution with a more hydrophilic residue.  
 
3.5.1   In vitro oxidative folding of t-TM EGF D4 (Y25T) 
Oxidative folding of reduced t-TM EGF D4 (Y25T) was performed using air 
oxidation and redox reagent-mediated folding: 
(a) Air oxidation-mediated folding of reduced t-TM EGF D4 (Y25T) was 
completed in approximately 72 hrs as judged by the Ellman!s test. 
Structural isoforms obtained from the reaction were resolved by reversed-
phase chromatography and three monomeric isoforms were obtained 
(Figure 3.28).  
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(b)  Folding of t-TM EGF D4 (Y25T) was performed in redox buffer over a 
period of 48 hrs. Like air oxidation, three monomeric isoforms were 
obtained (Figure 3.29).  
In both oxidative folding studies, the retention volume of the three monomeric 
isoforms obtained matched well with that of regioselectively-synthesized 
structural isoforms. This enabled the identification of peaks in the 
chromatogram, and the relative proportions of the three isoforms were 
calculated (Table 3.4: Pink columns). 
Results from both folding studies showed that t-TM EGF D4 has an altered 
folding preference after replacing the putative structural determinant of the 
canonical C1-C3, C2-C4 fold with a more hydrophilic residue ! That is, instead 
of folding into the canonical fold of the EGF-like domain, t-TM EGF D4 (Y25T) 
displayed a folding preference towards the non-canonical C1-C2, C3-C4 
isoform (Figure 3.30 and Figure 3.31).  
 
 
Table 3.4   Percentages of structural isoforms obtained from oxidative folding 
of t-TM EGF D4 (Y25T) in various conditions 
Oxidative folding of t-TM EGF D4 (Y25T) 
 (---)
a,b
 +6 M Gn.HCl
c
 








C1-C3, C2-C4 (Native) 22.78 ± 0.32 22.27 ± 0.42 8.16 ± 0.33 17.26 ± 0.45 
C1-C2, C3-C4 42.20 ± 0.36 42.25 ± 0.70 54.08 ± 0.52 45.92 ± 0.36 















Figure 3.28   Analysis of t-TM EGF D4 (Y25T) air oxidation products by reversed-phase 
chromatography. Retention volume of the three monomeric structural isoforms obtained were 
compared with that of regioselectively-synthesized structural isoforms. 
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Figure 3.29   Analysis of t-TM EGF D4 (Y25T) redox reagent-mediated oxidation products by 
reversed-phase chromatography. Retention volume of the three monomeric structural isoforms 
obtained were compared with that of regioselectively-synthesized structural isoforms. Abbreviations: 





Figure 3.30!!!Proportion of structural isoforms obtained from air oxidation-mediated folding of t-
TM EGF D4 and t-TM EGF D4 (Y25T). The dominant isoform obtained from t-TM EGF D4 is the 
canonical EGF-domain like (C1-C3, C2-C4) fold, while the dominant isoform obtained from t-TM EGF D4 




Figure 3.31! ! !Proportion of structural isoforms obtained from redox reagent-mediated oxidative 
folding of t-TM EGF D4 and t-TM EGF D4 (Y25T). The dominant isoform obtained from t-TM EGF D4 
is the canonical EGF-domain like (C1-C3, C2-C4) fold, while the dominant isoform obtained from t-TM 
EGF D4 (Y25T) is the non-canonical C1-C2, C3-C4 fold.  
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3.5.2   In vitro oxidative folding of t-TM EGF D4 (Y25T) in the 
presence of 6 M Gn.HCl  
Air oxidation and redox reagent-mediated folding of t-TM EGF D4 (Y25T) was 
performed with the inclusion of 6 M Gn.HCl in the folding buffer: 
(a)  For air oxidation in the presence of the denaturant, the reaction was 
completed in approximately 48 hrs as judged by the Ellman!s test. 
Analysis by reversed-phase chromatography revealed that all three 
monomeric isoforms were obtained (Figure 3.32). 
(b)   Redox reagent-mediated oxidative folding of t-TM EGF D4 (Y25T) in the 
presence of denaturant was allowed to proceed for 48 hours. It also 
yielded three monomeric isoforms (Figure 3.33).  
The relative proportion of the three structural isoforms obtained in both studies 
revealed that the folding tendency of t-TM EGF D4 (Y25T) was unaltered 
despite the presence of 6 M Gn.HCl in the folding buffer (Table 3.4: Blue 
columns). Interestingly, this observation was similar to that of t-TM EGF D5, 
where the presence of denaturant in the folding buffer did not change the 
folding tendency of this non-canonical EGF-like domain.  
 
3.5.3   The hydrophobic/aromatic residue, Tyr25, as the main 
structural determinant of t-TM EGF D4 
The relative proportion of the three structural isoforms obtained from the 
oxidative folding of t-TM EGF D4 in the presence of 6 M Gn.HCl was similar to 
that of t-TM EGF D4 (Y25T) folded under normal oxidative conditions (Figure 
3.34 and Figure 3.35). This suggests that hydrophobic interactions mediated 
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Figure 3.32   Analysis of t-TM EGF D4 (Y25T) products obtained from air oxidation in the 
presence of 6 M Gn.HCl by reversed-phase chromatography. Retention volume of the three 




Figure 3.33   Analysis of t-TM EGF D4 (Y25T) products obtained from redox reagent-mediated 
oxidation in the presence of 6 M Gn.HCl by reversed-phase chromatography. Retention volume of 
the three monomeric structural isoforms obtained were compared with that of regioselectively-




Figure 3.34!!!Proportion of structural isoforms obtained from air oxidation-mediated folding of t-





Figure 3.35! ! !Proportion of structural isoforms obtained from redox reagent-mediated oxidative 
folding of t-TM EGF D4 (+6 M Gn.HCl) and t-TM EGF D4 (Y25T).  
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Tyr25 of t-TM EGF D4 was the identity of the side-chain interactions that were 
being disrupted by 6 M Gn.HCl, resulting in the shift of folding tendency from 
C1-C3, C2-C4 (canonical EGF-like) to C1-C2, C3-C4. Moreover, the proportion of 
the canonical C1-C3, C2-C4 isoform obtained from the folding of t-TM EGF D4 
(Y25T) and t-TM EGF D5 under normal oxidative conditions, and t-TM EGF 
D4 in the presence of denaturant were similar (Figure 3.36 and Figure 3.37). 
This observation provide further evidence that the conserved 
hydrophobic/aromatic residue is the main structural determinant of the 
canonical C1-C3, C2-C4 EGF-like domain fold, with the disruption of which 





Figure 3.36!!!Comparison of structural isoform proportions obtained from air oxidation-mediated 
folding of t-TM EGF D4 (+6 M Gn.HCl), t-TM EGF D4 (Y25T) and t-TM EGF D5.  
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Figure 3.37! ! ! Comparison of structural isoform proportions obtained from redox reagent-
mediated oxidative folding of t-TM EGF D4 (+6 M Gn.HCl), t-TM EGF D4 (Y25T) and t-TM EGF D5.  
!
However, it should be noted that although the relative proportion of the non-
canonical C1-C2, C3-C4 isoform increased when t-TM EGF D4 was folded in 
the presence of 6 M Gn.HCl or when t-TM EGF D4 (Y25T) was folded under 
normal oxidative conditions, its level did not reach as high as that of t-TM EGF 
D5 (Figure 3.36 and Figure 3.37). This suggests that t-TM EGF D5 contains 
its own specific structural determinants for the non-canonical C1-C2, C3-C4 fold 
in addition to the lack of the conserved hydrophobic/aromatic residue that is 
needed for the canonical EGF-like domain fold. 
!Chapter 4: Conclusion 
!
! "#$!
4.1     Conclusion 
The proposal of the thermodynamic hypothesis by Nobel Prize Laureate C.B. 
Anfinsen in the 1960s [92] had fueled intensive research with aims to decipher 
the protein folding code. However, despite such efforts, only fragmentary 
information, which consists mainly of general principles, had been obtained 
over the years. The presence of gaps in our current knowledge of the protein 
folding code had motivated the work described in this thesis. Here, the folding 
code of the evolutionarily conserved EGF-like domain is studied to provide 
more insights into how an amino acid sequence is being interpreted to result 
in three-dimensional structural information.  
The EGF-like domain is a ubiquitous modular unit with diverse biological 
functions. All EGF-like domains consist of six conserved cysteine residues, 
with distinct hypervariability in the amino acid sequence of their inter-cysteine 
region. Although this hypervariability could explain the functional diversity of 
the various EGF-like domains, it has contributed to the puzzling question of 
how most EGF-like domains fold into their canonical C1-C3, C2-C4, C5-C6 
scaffold despite of the inconsistency in sequence information.  
A solution to this problem would involve the presence of conserved “structural 
determinants” embedded in the amino acid sequence of the EGF-like domain. 
These structural determinants could explain how the canonical three-looped 
structure of EGF-like domain is maintained in the midst of functional 
diversification. To find out the nature of these structural determinants, TM 
EGF D4 and TM EGF D5 were used as models for the study.  
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As TM EGF D4-D5 is the smallest co-factor active fragment of TM, interest in 
its structure-function relationship had resulted in interesting findings with 
regards to the structure of TM EGF D5. While TM EGF D4 folds into the 
canonical C1-C3, C2-C4, C5-C6 structure of the EGF-like domain, TM EGF D5 
does not. Instead, it folds into an alternate conformation stabilized by the C1-
C2, C3-C4, C5-C6 disulfide-connectivity. So how did this switch in conformation, 
from C1-C3, C2-C4 to C1-C2, C3-C4, occur? This switch could be attributed to a 
change in the physical-chemical properties of the canonical EGF-like 
domain!s structural determinants which will be manifested as a difference in 
inter-molecular force, thus affecting the overall thermodynamic property of the 
polypeptide chain to result in a different fold. Based on this reasoning, the 
relative contribution of various inter-molecular forces in the folding of TM EGF 
D4 and TM EGF D5 was determined to provide clues to the identity of the 
structural determinants involved. 
The first objective of this thesis was to narrow down the region where the 
structural determinants are located. Since the structural/disulfide-connectivity 
difference between TM EGF D4 and D5 lies in the first two disulfide bonds 
within their N-terminal segments (encompassing C1 to C4), it was of interest to 
see whether the folding information is located locally within that segment or 
non-locally in the C-terminal segment (encompassing C5 to C6). To this end, 
fully reduced, truncated versions of both domains were synthesized (t-TM 
EGF D4 and t-TM EGF D5) so that the oxidative folding of both domains could 
be performed without their respective C-terminal segments. 
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With the aid of regioselectively synthesized structural isoforms for peak 
identification in oxidative folding studies, results obtained from air oxidation 
and redox reagent-mediated oxidation studies showed that t-TM EGF D4 and 
t-TM EGF D5 still fold preferentially into their respective native structural 
isoforms despite the absence of the C-terminal segment. This suggest that 
the structural determinants of both domains lie locally within their N-terminal 
segments, encompassing C1 to C4. 
To next objective was to determine the relative contribution of side-chain 
interactions to the folding tendency of both domains. Here, 6 M Gn.HCl was 
included in the oxidative folding experiments to disrupt any side-chain 
interactions present within the folding peptide. This changed the folding 
tendency of t-TM EGF D4 from that of its native C1-C3, C2-C4 conformer to that 
of the C1-C2, C3-C4 conformer. On the contrary, the disruption of side-chain 
interactions did not affect the folding tendencies of t-TM EGF D5 at all, and 
even resulted in a slight decrease of the C1-C3, C2-C4 isoform. These 
observations suggested that side-chain interactions is needed to guide the 
fold of EGF-like domains towards its canonical C1-C3, C2-C4 conformer. If 
side-chain interactions is absent, the default conformation adopted would be 
that of the C1-C2, C3-C4 conformer. When these findings were put into 
perspective, this meant that the structural determinants of the C1-C3, C2-C4 
fold is selected for optimal engagement in side-chain interactions, while the 
converse is true for the C1-C2, C3-C4 fold.  
Although Gn.HCl disrupts side-chain interactions, its effect could not be 
differentiated between the disruption of electrostatic interactions or 
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hydrophobic interactions. Thus, 0.5 M NaCl was included in the oxidative 
folding experiments to disrupt any electrostatic interactions, as well as, to 
increase the hydrophobic effect within the folding peptides. Unlike 6 M 
Gn.HCl, the inclusion of 0.5 M NaCl did not alter the folding tendency of t-TM 
EGF D4, and even increased the proportion of its native C1-C3, C2-C4 
structural isoform. Therefore, this suggests that electrostatic interactions is not 
the nature of the side-chain interactions disrupted by 6 M Gn.HCl and that the 
increase in the canonical C1-C3, C2-C4 isoform was attributed to the increased 
hydrophobic effect. As for t-TM EGF D5, the presence of 0.5 M NaCl also did 
not change its folding tendency, but an increase in the proportion of the C1-C3, 
C2-C4 isoform was observed. These results collectively identifies the role of 
hydrophobic interactions in guiding the fold of the EGF-like domain towards 
the C1-C3, C2-C4 fold. 
The final objective of this thesis was to identify key hydrophobic residues as 
the structural determinants of the canonical EGF-like domain fold. A sequence 
alignment of canonical EGF-like domains from various proteins helped identify 
a conserved hydrophobic/aromatic residue which is located two residues N-
terminal to the C4 residue. Interestingly, this conserved hydrophobic/aromatic 
residue is not present in its corresponding position in t-TM EGF D5. When the 
structures of various canonical EGF-like domains were examined, this 
conserved hydrophobic/aromatic residue mainly make contacts with residues 
in the first inter-cysteine loop of the domain. In TM EGF D4, this contact is 
present between Ala11 and Tyr25. However, this contact is not present in the 
equivalent positions in t-TM EGF D5 (Thr6 and Ala18).  
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With these analysis, an attempt was made to verify this hydrophobic/aromatic 
residue as the structural determinant of the canonical fold of the EGF-like 
domain. To this end, the Tyr25 residue of t-TM EGF D4 was substituted with a 
more hydrophilic threonine residue. If the conserved hydrophobic/aromatic 
residue is a structural determinant of the C1-C3, C2-C4 fold, the placement of 
this residue into t-TM EGF D4 should decrease its folding towards the C1-C3, 
C2-C4 conformer. Indeed, when t-TM EGF D4 (Y25T) was folded under 
oxidative conditions, with and without denaturant, it displayed a preferential 
folding towards the non-canonical C1-C2, C3-C4 conformer. More importantly, 
this was accompanied by a sharp drop in the proportion of the canonical C1-
C3, C2-C4 conformer. This suggests that the conserved hydrophobic/aromatic 
residue is indeed the main structural determinant of the canonical C1-C3, C2-
C4 fold of the EGF-like domain.  
! "#$!
4.2     Future Work 
4.2.1   Verifying the structural determinant of the canonical 
EGF-like domain fold 
Future work for the current study would involve the continued focus on the 
verification of the conserved hydrophobic/aromatic residue as the structural 
determinant of canonical EGF-like domain fold. To this end, an alternate 
strategy involving the insertion of the hydrophobic/aromatic residue into t-TM 
EGF D5 at its equivalent position is proposed. In support of the current 
evidences, this insertion is expected to increase the proportion of the 
canonical C1-C3, C2-C4 fold in t-TM EGF D5.  
 
4.2.2   The role of the structural determinant in the transition 
state of protein folding 
After confirming the identity of the structural determinant, its role in the 
transition state of protein folding should be examined. For t-TM EGF D4, the 
slow kinetics of oxidative folding and the unique chemistry of the disulfide 
bond meant that folding intermediates could be trapped in a time course 
manner using either chemical modification (of free thiol groups) or acid-
trapping. The structures of these trapped intermediates could then be 
analyzed by NMR to examine the contacts (i.e. native or non-native) made by 
this structural determinant during the process of folding. 
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4.2.3   Extending the study to other canonical EGF-like 
domains 
When t-TM EGF D4 and t-TM EGF D5 were folded in the presence of 6 M 
Gn.HCl, the loss of side-chain interactions disfavored folding into the C1-C3, 
C2-C4 isoform for both domains. On the contrary, the increased hydrophobic 
effect mediated by 0.5 M NaCl drove up the proportion of C1-C3, C2-C4 in both 
domains. These generalized effect, without regards to the exact identities of 
the EGF-like domain, meant that the conclusion regarding hydrophobic 
interactions as the dominant driving force in dictating the C1-C3, C2-C4 fold 
could be applied to other canonical EGF-like domains as well.  
However, to provide further support for the conclusion, the same set of 
experiments performed on t-TM EGF D4 and D5 should be applied to other 
canonical EGF-like domains (e.g. EGF-like domain 1 of coagulation factor VII 
and pro-neuregulin-1 EGF-like domain).  
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4.3     Implication of Findings 
The main objective of this thesis is to provide more insights into the 
interpretation of the protein folding code. Here, attempts were made to shed 
light on the nature of structural determinants which play a role in maintaining 
the overall fold of evolutionarily conserved protein domains despite 
hypervariability in their amino acid sequences.  
The concept of structural determinants deviate from the common definition of 
the protein folding code. In the common definition, the three-dimensional 
structure of a protein is considered to be dictated by the totality of the amino 
acid sequence. However, in the case of structural determinants, only certain 
specific residues fulfill the role of a guide in the folding decision of a protein. 
This, as mentioned previously, would allow functional diversification to take 
place on a single protein scaffold. 
The results obtained from this study demonstrated that a simple switch in the 
requirement of hydrophobic interactions to the non-requirement in the folding 
domain ! hypothesized to be mediated by the switch in the physical-chemical 
properties of the structural determinants ! is enough to generate a novel 
protein fold from a single domain platform. Therefore, a single protein modular 
unit not only serves as the platform for functional diversification, it also serves 
as a basis for the evolution of protein structure. This new protein structure 
could in turn participate in novel functions, thus amplifying the rate of 
functional diversification. In such a case, an exponential rate of protein 
evolution could be achieved. This could explain the exponential increase in 
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the complexity of life forms since the beginning of life approximately 3.8 billion 
years ago ! i.e. For a long time the rate of increase in the complexity of life-
forms is very slow. Only in the last 350 million years there was an exponential 
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Figure A3.1   ESI-MS mass spectrum of t-TM EGF D4 C1-C3, C2-C4 (native) isoform. (A) Mass 
spectrum showing the +3 (m/z: 1096) and +2 (m/z: 1643) charge states of the folded peptide. (B) 












Figure A3.2   ESI-MS mass spectrum of t-TM EGF D4 C1-C2, C3-C4 isoform. (A) Mass spectrum 
showing the +3 (m/z: 1096) and +2 (m/z: 1643) charge states of the folded peptide. (B) Reconstructed 











Figure A3.3   ESI-MS mass spectrum of t-TM EGF D4 C1-C4, C2-C3 isoform. (A) Mass spectrum 
showing the +3 (m/z: 1096) and +2 (m/z: 1643) charge states of the folded peptide. (B) Reconstructed 






Figure A3.4   Reconstructed ESI-MS mass spectrum of t-TM EGF D5 C1-C3, C2-C4 isoform. 
Reconstructed mass spectrum was obtained using the “Peptide Reconstruct” function of the Analyst
®
 
software. Shown here is the isotopic cluster corresponding to the +1 charge state of the folded peptide. 
The difference of 1 Da between one isotopic mass to the next confirmed the assignment of the +1 





Figure A3.5   Reconstructed ESI-MS mass spectrum of t-TM EGF D5 C1-C2, C3-C4 (native) 
isoform. Reconstructed mass spectrum was obtained using the “Peptide Reconstruct” function of the 
Analyst
®
 software. Shown here is the isotopic cluster corresponding to the +1 charge state of the folded 
peptide. The difference of 1 Da between one isotopic mass to the next confirmed the assignment of the 




Figure A3.6   Reconstructed ESI-MS mass spectrum of t-TM EGF D5 C1-C4, C2-C3 isoform. 
Reconstructed mass spectrum was obtained using the “Peptide Reconstruct” function of the Analyst
®
 
software. Shown here is the isotopic cluster corresponding to the +1 charge state of the folded peptide. 
The difference of 1 Da between one isotopic mass to the next confirmed the assignment of the +1 
charge state to the isotopic cluster.  
!
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Table A3.1   Student!s t-test (independent samples) for t-TM EGF D4 structural isoforms derived from air oxidation and redox reagent-mediated 
oxidation 
t-TM EGF D4: 
Air Oxidation versus Redox Buffer System   
 Arcsine Transformed Values 
 Air Oxidation Redox Buffer System 
Test statistics 


















C1-C3, C2-C4 (Native) 55.26 0.42 56.21 0.35 0.95 0.32 3.00 4 0.02 
C1-C2, C3-C4 27.36 0.47 25.81 0.42 -1.55 0.36 -4.26 4 0.01 
C1-C4, C2-C3 19.68 0.56 20.23 0.24 0.55 0.35 1.57 4 0.10 
a 





Table A3.2   Student!s t-test (independent samples) for t-TM EGF D5 structural isoforms derived from air oxidation and redox reagent-mediated 
oxidation 
t-TM EGF D5: 
Air Oxidation versus Redox Buffer System   
 Arcsine Transformed Values 
 Air Oxidation Redox Buffer System 
Test statistics 


















C1-C3, C2-C4 26.97 0.24 26.82 0.07 -0.14 0.15 -0.98 4 0.19 
C1-C2, C3-C4 (Native) 51.00 0.38 51.16 0.63 0.16 0.42 0.38 4 0.36 
C1-C4, C2-C3 25.87 0.22 25.81 0.72 -0.05 0.43 -0.12 4 0.45 
a 
Statistical significance when p-value is smaller than 0.05.  
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Table A3.3   Student!s t-test (independent samples) for t-TM EGF D4 structural isoforms derived from air oxidation (with 6 M Gn.HCl) and 
redox reagent-mediated oxidation (with 6 M Gn.HCl) 
t-TM EGF D4: 
Air Oxidation (with 6 M Gn.HCl) versus Redox Buffer System (with 6 M Gn.HCl) 
 Arcsine Transformed Values 
 
Air Oxidation  
(+6 M Gn.HCl) 
Redox Buffer System  
(+6 M Gn.HCl) 
Test statistics 


















C1-C3, C2-C4 (Native) 25.46 0.85 34.02 0.60 8.57 0.60 14.23 4 <0.01 
C1-C2, C3-C4  46.56 0.54 43.44 0.18 -3.12 0.33 -9.51 4 <0.01 
C1-C4, C2-C3 32.46 0.52 27.56 0.50 -4.89 0.42 -11.77 4 <0.01 
a 




Table A3.4   Student!s t-test (independent samples) for t-TM EGF D5 structural isoforms derived from air oxidation (with 6 M Gn.HCl) and 
redox reagent-mediated oxidation (with 6 M Gn.HCl) 
t-TM EGF D5: 
Air Oxidation (with 6 M Gn.HCl) versus Redox Buffer System (with 6 M Gn.HCl) 
 Arcsine Transformed Values 
 
Air Oxidation  
(+6 M Gn.HCl) 
Redox Buffer System  
(+6 M Gn.HCl) 
Test statistics 


















C1-C3, C2-C4  24.87 0.26 25.92 0.11 1.05 0.16 6.43 4 <0.01 
C1-C2, C3-C4 (Native) 51.82 0.54 51.63 0.46 -0.20 0.41 -0.48 4 0.33 
C1-C4, C2-C3 26.93 0.48 25.15 0.46 -0.78 0.38 -2.04 4 0.11 
a 
Statistical significance when p-value is smaller than 0.05.  
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Table A3.5   Student!s t-test (independent samples) for t-TM EGF D4 structural isoforms derived from air oxidation and air oxidation (with 6 M 
Gn.HCl) 
t-TM EGF D4: 
Air Oxidation versus Air Oxidation (with 6 M Gn.HCl) 
 Arcsine Transformed Values 
 
Air Oxidation Air Oxidation  
(+6 M Gn.HCl) 
Test statistics 


















C1-C3, C2-C4 (Native) 55.26 0.42 25.45 0.85 -29.81 0.55 -54.35 4 <0.01 
C1-C2, C3-C4  27.36 0.47 46.56 0.54 19.20 0.41 46.40 4 <0.01 
C1-C4, C2-C3 19.68 0.56 32.46 0.52 12.78 0.44 28.85 4 <0.01 
a 
Statistical significance when p-value is smaller than 0.05.  
 
 
Table A3.6   Student!s t-test (independent samples) for t-TM EGF D4 structural isoforms derived from redox reagent-mediated oxidation and 
redox reagent-mediated oxidation (with 6 M Gn.HCl) 
t-TM EGF D4: 
Redox Buffer System versus Redox Buffer System (with 6 M Gn.HCl) 
 Arcsine Transformed Values 
 
Redox Buffer System Redox Buffer System  
(+6 M Gn.HCl) 
Test statistics 


















C1-C3, C2-C4 (Native) 56.21 0.35 34.02 0.60 -22.19 0.40 -55.03 4 <0.01 
C1-C2, C3-C4  25.81 0.42 43.44 0.18 17.63 0.26 67.42 4 <0.01 
C1-C4, C2-C3 20.23 0.24 27.56 0.50 7.33 0.32 22.99 4 <0.01 
a 
Statistical significance when p-value is smaller than 0.05.  
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Table A3.7   Student!s t-test (independent samples) for t-TM EGF D5 structural isoforms derived from air oxidation and air oxidation (with 6 M 
Gn.HCl) 
t-TM EGF D5: 
Air Oxidation versus Air Oxidation (with 6 M Gn.HCl) 
 Arcsine Transformed Values 
 
Air Oxidation Air Oxidation  
(+6 M Gn.HCl) 
Test statistics 


















C1-C3, C2-C4  26.97 0.24 24.87 0.26 -2.10 0.21 -10.20 4 <0.01 
C1-C2, C3-C4 (Native) 51.00 0.38 51.82 0.54 0.82 0.38 2.16 4 0.05 
C1-C4, C2-C3 25.87 0.22 26.93 0.48 1.07 0.30 3.51 4 0.01 
a 




Table A3.8   Student!s t-test (independent samples) for t-TM EGF D5 structural isoforms derived from redox reagent-mediated oxidation and 
redox reagent-mediated oxidation (with 6 M Gn.HCl) 
t-TM EGF D5: 
Redox Buffer System versus Redox Buffer System (with 6 M Gn.HCl) 
 Arcsine Transformed Values 
 
Redox Buffer System Redox Buffer System  
(+6 M Gn.HCl) 
Test statistics 


















C1-C3, C2-C4  26.82 0.07 25.92 0.11 -0.90 0.08 -11.53 4 <0.01 
C1-C2, C3-C4 (Native) 51.16 0.63 51.63 0.46 0.46 0.45 1.04 4 0.18 
C1-C4, C2-C3 25.81 0.72 26.15 0.46 0.34 0.49 0.69 4 0.26 
a 
Statistical significance when p-value is smaller than 0.05.  
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Table A3.9   Student!s t-test (independent samples) for t-TM EGF D4 structural isoforms derived from redox reagent-mediated oxidation and 
redox reagent-mediated oxidation (with 0.5 M NaCl) 
t-TM EGF D4: 
Redox Buffer System versus Redox Buffer System (with 0.5 M NaCl) 
 Arcsine Transformed Values 
 
Redox Buffer System Redox Buffer System  
(+0.5 M NaCl) 
Test statistics 


















C1-C3, C2-C4 (Native) 56.21 0.35 59.78 0.57 3.56 0.39 9.19 4 <0.01 
C1-C2, C3-C4  25.81 0.42 24.48 0.34 -1.33 0.31 -4.29 4 0.01 
C1-C4, C2-C3 20.23 0.24 16.60 0.51 -3.63 0.32 -11.17 4 <0.01 
a 




Table A3.10   Student!s t-test (independent samples) for t-TM EGF D5 structural isoforms derived from redox reagent-mediated oxidation and 
redox reagent-mediated oxidation (with 0.5 M NaCl) 
t-TM EGF D5: 
Redox Buffer System versus Redox Buffer System (with 0.5 M NaCl) 
 Arcsine Transformed Values 
 
Redox Buffer System Redox Buffer System  
(+0.5 M NaCl) 
Test statistics 


















C1-C3, C2-C4  26.82 0.07 28.87 0.29 2.05 0.17 11.77 4 <0.01 
C1-C2, C3-C4 (Native) 51.16 0.63 47.53 1.02 -3.64 0.69 -5.25 4 <0.01 
C1-C4, C2-C3 25.81 0.72 28.15 1.36 2.34 0.88 2.64 4 0.03 
a 
Statistical significance when p-value is smaller than 0.05.  
